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A B S T R A C T
Background
When sufficient maternal breast milk is not available, alternative forms of enteral nutrition for preterm or low birth weight (LBW)
infants are donor breast milk or artificial formula. Donor breast milk may retain some of the non-nutritive benefits of maternal breast
milk for preterm or LBW infants. However, feeding with artificial formula may ensure more consistent delivery of greater amounts of
nutrients. Uncertainty exists about the balance of risks and benefits of feeding formula versus donor breast milk for preterm or LBW
infants.
Objectives
To determine the effect of feeding with formula compared with donor breast milk on growth and development in preterm or low birth
weight (LBW) infants.
Search methods
We used the Cochrane Neonatal search strategy, including electronic searches of the Cochrane Central Register of Controlled Trials
(CENTRAL; 2019, Issue 5), Ovid MEDLINE, Embase, and the Cumulative Index to Nursing and Allied Health Literature (3 May
2019), as well as conference proceedings, previous reviews, and clinical trials.
Selection criteria
Randomised or quasi-randomised controlled trials (RCTs) comparing feeding with formula versus donor breast milk in preterm or
LBW infants.
Data collection and analysis
Two review authors assessed trial eligibility and risk of bias and extracted data independently. We analysed treatment effects as described
in the individual trials and reported risk ratios (RRs) and risk differences (RDs) for dichotomous data, and mean differences (MDs) for
continuous data, with respective 95% confidence intervals (CIs). We used a fixed-effect model in meta-analyses and explored potential
causes of heterogeneity in subgroup analyses. We assessed the certainty of evidence for the main comparison at the outcome level using
GRADE methods.
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Main results
Twelve trials with a total of 1879 infants fulfilled the inclusion criteria. Four trials compared standard term formula versus donor breast
milk and eight compared nutrient-enriched preterm formula versus donor breast milk. Only the five most recent trials used nutrient-
fortified donor breast milk. The trials contain various weaknesses in methodological quality, specifically concerns about allocation
concealment in four trials and lack of blinding in most of the trials. Most of the included trials were funded by companies that made
the study formula.
Formula-fed infants had higher in-hospital rates of weight gain (mean difference (MD) 2.51, 95% confidence interval (CI) 1.93 to
3.08 g/kg/day), linear growth (MD 1.21, 95% CI 0.77 to 1.65 mm/week) and head growth (MD 0.85, 95% CI 0.47 to 1.23 mm/
week). These meta-analyses contained high levels of heterogeneity. We did not find evidence of an effect on long-term growth or
neurodevelopment. Formula feeding increased the risk of necrotising enterocolitis (typical risk ratio (RR) 1.87, 95% CI 1.23 to 2.85;
risk difference (RD) 0.03, 95% CI 0.01 to 0.05; number needed to treat for an additional harmful outcome (NNTH) 33, 95% CI 20
to 100; 9 studies, 1675 infants).
The GRADE certainty of evidence was moderate for rates of weight gain, linear growth, and head growth (downgraded for high levels
of heterogeneity) and was moderate for neurodevelopmental disability, all-cause mortality, and necrotising enterocolitis (downgraded
for imprecision).
Authors’ conclusions
In preterm and LBW infants, moderate-certainty evidence indicates that feeding with formula compared with donor breast milk, either
as a supplement to maternal expressed breast milk or as a sole diet, results in higher rates of weight gain, linear growth, and head growth
and a higher risk of developing necrotising enterocolitis. The trial data do not show an effect on all-cause mortality, or on long-term
growth or neurodevelopment.
P L A I N L A N G U A G E S U M M A R Y
Formula versus donor breast milk for feeding preterm or low birth weight infants
Review question
When a mother’s own breast milk is not available, does feeding preterm or low birth weight infants with formula rather than donor
breast milk affect digestion, growth and the risk of severe bowel problems?
Background
Preterm infants often find artificial formula more difficult to digest than human milk, and concerns exist that formula could increase
the risk of severe bowel problems. If preterm infants are fed with donor breast milk (when a mother’s own breast milk is insufficient
or unavailable), rather than an artificial formula, this might reduce the risk of these problems. Donor breast milk, however, is more
expensive than many formulas, and may not contain sufficient amounts of key nutrients to ensure optimal growth for preterm or low
birth weight infants. Given these concerns, we have reviewed all of the available evidence from clinical trials that compared formula
versus donor breast milk for feeding preterm or low birth weight infants.
Study characteristics
We found 12 completed trials (involving 1871 infants). Most trials, particularly those trials conducted more recently, used reliable
methods. Evidence is up to date as of 3 May 2019.
Key results
The combined analysis of data from these trials shows that feeding with formula increases rates of growth during the hospital stay, but
is associated with a higher risk of developing the severe gut disorder called ’necrotising enterocolitis’. There is no evidence of an effect
on survival or longer-term growth and development.
Conclusions
The currently available evidence suggests that feeding preterm infants with artificial formula (rather than donor breast milk when
mother’s own breast milk is not available) is associated with faster rates of growth, but with a near-doubling of the risk of developing
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necrotising enterocolitis. Further, larger trials could provide stronger and more precise evidence to help clinicians and families make
informed choices about this issue. Currently, four such trials (involving more than 1100 infants) are ongoing internationally, and we
plan to include the data from these trials in this review when these become available.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Formula (term or preterm) compared to donor breast milk (unfortified or fortified) for feeding preterm or low birth weight infants
Patient or population: preterm or low birth weight infants
Setting: neonatal unit
Intervention: formula (term or preterm)
Comparison: donor breast milk (unfortified of fortified)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with donated
breast milk (unfortified
or fortified)
Risk with formula (term
or preterm)
Weight gain (g/ kg/ day) - MD 2.51 higher
(1.93 higher to 3.08
higher)
- 1028
(9 studies)
Moderatea I² = 90%
Linear growth (crown-
heel length mm/ week)
- MD 1.21 higher
(0.77 higher to 1.65
higher)
- 820
(8 studies)
Moderatea I² = 68%
Head growth (mm/
week)
- MD 0.85 higher
(0.47 higher to 1.23
higher)
- 894
(8 studies)
Moderatea I² = 74%
Neurodevelopmental
disability
Study populat ion RR 1.21
(0.62 to 2.35)
400
(2 studies)
Moderateb
73 per 1000 88 per 1000
(45 to 171)
All- cause mortality Study populat ion RR 1.1
(0.8 to 1.5)
1527
(7 studies)
Moderateb
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86 per 1000 94 per 1000
(69 to 128)
Necrotising enterocol-
itis
Study populat ion RR 1.87
(1.23 to 2.85)
1675
(9 studies)
Moderateb
36 per 1000 67 per 1000
(44 to 102)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
aDowngraded one level for heterogeneity.
bDowngraded one level for imprecision.
CI: conf idence interval; MD: mean dif ference; RR: risk rat io
5
F
o
rm
u
la
v
e
rsu
s
d
o
n
o
r
b
re
a
st
m
ilk
fo
r
fe
e
d
in
g
p
re
te
rm
o
r
lo
w
b
irth
w
e
ig
h
t
in
fa
n
ts
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
B A C K G R O U N D
Maternal breast milk is the recommended form of enteral nutri-
tion for preterm or low birth weight (LBW) infants (AAP 2012).
Breast milk contains non-nutrient factors including immunoglob-
ulins and lactoferrin that may promote intestinal adaptation and
maturation, improve enteral feed tolerance, and protect against
infective and inflammatory disorders (Agostoni 2010; Arslanoglu
2013).
When sufficient maternal breast milk is not available, the two
common alternatives available for feeding preterm or LBW infants
are artificial formula and donor breast milk (donated by other
lactating women). These may be given either as the sole form
of enteral feeding or as a supplement to maternal breast milk (
Klingenberg 2012).
Description of the condition
Providing appropriate nutrition for preterm or LBW infants is a
critical component of neonatal care. Early enteral nutrition strate-
gies may have a substantial impact on clinically important out-
comes, such as necrotising enterocolitis and invasive infection.
These infectious and inflammatory complications may increase
the risk of mortality and other morbidities and adversely affect
long-term growth and neurodevelopmental outcomes.
Description of the intervention
A variety of artificial formulas (usually adapted from cow’s milk)
are available. These vary in energy, protein and mineral content
but can, broadly, be considered as:
• standard ’term’ formula, designed for term infants based on
the composition of mature breast milk; the typical energy content
is approximately between 67 kCal/100 mL to 70 kCal/100 mL;
• nutrient-enriched ’preterm’ formula, designed to provide
nutrient intakes to match intrauterine accretion rates (Tsang
1993); these are energy-enriched (typically up to approximately
80 kCal/100 mL) and variably protein- and mineral-enriched
(Fewtrell 1999).
The comparison arm for the intervention is donor breast milk.
Expressed breast milk from donor mothers, usually mothers who
have delivered at term, generally has a lower content of energy
and protein than term formula milk (Gross 1980; Gross 1981).
The macronutrient content of donor breast milk is not compro-
mised substantially by modern pasteurisation methods but lev-
els of immunoactive components might be reduced (Peila 2016;
Castro 2019). Donor human milk also varies with regard to fat,
energy and protein content, depending upon the stage of lactation
at which it is collected. Milk expressed from the donor’s lactating
breast usually has a higher energy and protein content than that
collected from the contralateral breast (’drip’ breast milk) (Lucas
1978).
How the intervention might work
There is concern that the nutritional requirements of preterm or
LBW infants, who are born with relatively impoverished nutrient
reserves and are subject to additional metabolic stresses compared
with term infants, may not be fully met by enteral feeding with
donor breast milk (Hay 1994; Schanler 1995). These deficien-
cies may have adverse consequences for growth and development.
However, a major putative benefit of donor breast milk is that the
delivery of immunoprotective and growth factors to the imma-
ture gut mucosa may prevent serious adverse outcomes, includ-
ing necrotising enterocolitis and invasive infection (Lucas 1990;
Beeby 1992).
Why it is important to do this review
Given the potential for the type of enteral nutrition to affect im-
portant outcomes for preterm or LBW infants, and since uncer-
tainty exists about the balance between the putative benefits and
harms, an attempt to detect, appraise and synthesise evidence from
randomised controlled trials (RCTs) is merited.
O B J E C T I V E S
To determine the effect of feeding with formula compared with
donor breast milk on growth and development in preterm or low
birth weight (LBW) infants.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Controlled trials using random or quasi-random participant allo-
cation.
Types of participants
Preterm (< 37 weeks’ gestation at birth) or LBW (< 2500 g) infants.
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Types of interventions
Enteral feeding (orally or via gastric or transpyloric feeing tubes)
with formula versus donor breast milk. The allocated milk feed
may have been a supplement to maternal breast milk or have
formed the entire enteral intake (sole diet).
Trials in which parenteral (intravenous) nutritional support was
available during the period of advancement of enteral feeds were
acceptable provided that the groups received similar treatment
other than the type of milk feed.
Types of outcome measures
Primary outcomes
Growth
• Short-term growth: time to regain birth weight and
subsequent rates of weight gain, linear growth, head growth or
skinfold thickness growth, up to six months post-term.
• Long-term growth: weight, height or head circumference
(and/or proportion of infants who remain below the 10th
percentile for the index population’s distribution), assessed at
intervals from six months post-term.
Neurodevelopment
• Death or severe neurodevelopmental disability, defined as
any one, or combination of the following: non-ambulant
cerebral palsy, developmental delay (developmental quotient <
70), auditory and visual impairment. We planned to analyse each
component individually as well as part of the composite
outcome.
• Neurodevelopmental scores in children aged at least 12
months, measured using validated assessment tools.
• Cognitive and educational outcomes in children aged more
than five years old.
Secondary outcomes
• All-cause mortality, during the neonatal period and prior to
hospital discharge.
• Necrotising enterocolitis, confirmed at surgery or autopsy
or diagnosed by at least two of the following clinical features.
◦ Abdominal radiograph showing pneumatosis
intestinalis or gas in the portal venous system or free air in the
abdomen.
◦ Abdominal distension with abdominal radiograph
with gaseous distension or frothy appearance of bowel lumen (or
both).
◦ Blood in stool.
◦ Lethargy, hypotonia or apnoea (or combination of
these).
• Days after birth to establish full enteral feeding
(independently of parenteral nutrition).
• Feeding intolerance, defined as a requirement to cease
enteral feeds and commence parenteral nutrition.
• Incidence of invasive infection, as determined by culture of
bacteria or fungus from blood, cerebrospinal fluid, urine or from
a normally sterile body space.
Search methods for identification of studies
We used the standard search strategy of Cochrane Neonatal (
neonatal.cochrane.org).
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL; 2019, Issue 5), Ovid MEDLINE (1946 to 3 May
2019), OVID Embase (1974 to 3 May 2019), OVID Maternity
& Infant Care Database (1971 to 3 May 2019), and the Cumu-
lative Index to Nursing and Allied Health Literature (1982 to 3
May 2019) using a combination of text words and MeSH terms
described in Appendix 1. We limited the search outputs with the
relevant search filters for clinical trials as recommended in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We did not apply any language restrictions.
We searched ClinicalTrials.gov and the World Health Organiza-
tion’s International Trials Registry and Platform ( www.who.int/
ictrp/en/), for completed or ongoing trials.
Searching other resources
We examined reference lists in previous reviews and included stud-
ies. We searched the proceedings of the annual meetings of the
Pediatric Academic Societies (1993 to 2019), the European So-
ciety for Paediatric Research (1995 to 2019), the Royal College
of Paediatrics and Child Health (2000 to 2019), and the Perina-
tal Society of Australia and New Zealand (2000 to 2019). Trials
reported only as abstracts were eligible if sufficient information
was available from the report, or from contact with the authors,
to fulfil the inclusion criteria.
Data collection and analysis
We used the standard methods of Cochrane Neonatal.
Selection of studies
We screened the title and abstract of all studies identified by the
above search strategy and two review authors (NDE, WM) inde-
pendently assessed the full articles for all potentially relevant trials.
We excluded those studies that did not meet all of the inclusion
criteria and we stated the reason for exclusion. We discussed any
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disagreements until consensus was achieved. We illustrated the
screening and selection outcomes in a flowchart (PRISMA 2009).
Data extraction and management
Two review authors (NDE, WM) extracted data independently
using a data collection form to aid extraction of information on
design, methodology, participants, interventions, outcomes and
treatment effects from each included study. We discussed any dis-
agreements until we reached a consensus. If data from the trial
reports were insufficient, we contacted the trialists for further in-
formation.
Assessment of risk of bias in included studies
Two review authors (NDE, WM) independently assessed the risk
of bias (low, high, or unclear) of all included trials using the
Cochrane ’Risk of bias’ tool for the following domains (Higgins
2011).
• Sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding of participants and personnel (performance bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective reporting (reporting bias).
• Any other bias.
We resolved any disagreements by discussion or by including a
third review author (MQ). See Appendix 2 for a detailed descrip-
tion of risk of bias for each domain.
Measures of treatment effect
We calculated risk ratios (RRs) and risk differences (RDs) for
dichotomous data and mean differences (MDs) for continuous
data, with respective 95% confidence intervals (CIs). When it was
deemed appropriate to combine two or more study arms, we ob-
tained the treatment effects from the combined data using the
methods described in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011). We determined the number
needed to treat for an additional beneficial outcome (NNTB) or
additional harmful outcome (NNTH) for a statistically significant
difference in the RD.
Unit of analysis issues
The unit of analysis was the participating infant in individually
randomised trials and the neonatal unit (or subunit) for cluster-
RCTs. For cluster-RCTs, we planned to undertake analyses at the
level of the individual while accounting for the clustering in the
data using the methods recommended in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011)
Dealing with missing data
Where data were missing, and could not be derived as described,
we approached the analysis of missing data as follows.
• We contacted the original study investigators to request the
missing data.
• Where possible, we imputed missing standard deviations
(SDs) using the coefficient of variation or calculated the SD from
other statistics including standard errors, CIs, t values and P
values.
• If we assumed the data to be missing at random, we
analysed the data without imputing any missing values.
• If we could not make this assumption, then we planned to
impute the missing outcomes with replacement values, assuming
all to have a poor outcome. We planned sensitivity analyses to
assess any changes in the direction or magnitude of effect
resulting from data imputation.
Assessment of heterogeneity
Two review authors (NDE, WM) assessed clinical heterogeneity,
with a meta-analysis conducted only when both agreed that study
participants, interventions and outcomes were sufficiently similar.
We examined the treatment effects of individual trials and hetero-
geneity between trial results by inspecting the forest plots. We cal-
culated the I² statistic for each analysis to quantify inconsistency
across studies and described the percentage of variability in effect
estimates that may be due to heterogeneity rather than to sampling
error. If we detected moderate or high heterogeneity (I² > 50%),
we would explore the possible causes (for example, differences in
study design, participants, interventions or completeness of out-
come assessments).
Assessment of reporting biases
If more than 10 trials were included in a meta-analysis, we planned
to examine a funnel plot for asymmetry.
Data synthesis
We used fixed-effect models for meta-analysis (as per Cochrane
Neonatal recommendations). Where moderate or high hetero-
geneity existed, we planned to examine the potential causes in
subgroup and sensitivity analyses.
Certainty of evidence
We assessed the certainty of evidence for the main comparisons at
the outcomes level using the GRADE approach to assess the cer-
tainty of evidence for the following outcomes: growth, neurode-
velopmental disability, all-cause mortality, and necrotising entero-
colitis (Schünemann 2013; see Appendix 3).
Two review authors (NDE, WM) independently assessed the cer-
tainty of the evidence for each of these outcomes. We considered
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evidence from RCTs as high certainty but downgraded one level
for serious (or two levels for very serious) limitations based upon
the following: design (risk of bias), consistency across studies, di-
rectness of the evidence, precision of estimates and presence of
publication bias. We used the Guideline Development Tool to
create a ’Summary of findings’ table to report the certainty of the
evidence (GRADEpro GDT 2015).
Subgroup analysis and investigation of heterogeneity
We planned the following subgroup analyses of trials to compare:
• formula versus donor breast milk given as (i) a sole diet or
(ii) a supplement to maternal expressed breast milk;
• formula versus donor breast milk that is (i) unfortified or
(ii) nutrient-fortified (defined as supplementation with more
than one of the following components: protein, fat, carbohydrate
or minerals).
R E S U L T S
Description of studies
Results of the search
See: Figure 1.
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Figure 1. Study flow diagram: 2019 review update.
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We included one new trial (12 trials in total) (Costa 2018). We
excluded two new full-text reports (Brandstetter 2018; Castellano
2019) (14 reports in total).
One report is awaiting assessment (Perez 2015).
We identified four ongoing trials (See: Characteristics of ongoing
studies).
Included studies
Twelve trials fulfilled the review eligibility criteria (Raiha 1976;
Davies 1977; Schultz 1980; Gross 1983; Tyson 1983; Lucas
1984a; Lucas 1984b; Schanler 2005; Cristofalo 2013; Corpeleijn
2016; O’Connor 2016; Costa 2018).
All trials were undertaken in neonatal units in Europe and North
America. Seven of the trials were conducted more than 30 years
ago (Raiha 1976; Davies 1977; Schultz 1980; Gross 1983; Tyson
1983; Lucas 1984a; Lucas 1984b). Five trials have been un-
dertaken since the year 2000 (Schanler 2005; Cristofalo 2013;
Corpeleijn 2016; O’Connor 2016; Costa 2018). For further de-
tails see Characteristics of included studies.
Participants
A total of 1879 infants took part in the included trials. Most par-
ticipants were clinically stable infants of gestational age at birth <
32 weeks’ or birth weight < 1800 g. Most trials excluded infants
who were small for gestational age at birth and infants with con-
genital anomalies or gastrointestinal or neurological problems.
Interventions
The trials varied according to type of formula (term or preterm),
and whether the intervention was a sole diet or a supplement to
mother’s own milk.
• Four trials compared feeding with term formula versus
unfortified donor breast milk (Raiha 1976; Davies 1977; Schultz
1980; Gross 1983). In all of these trials, term formula or donor
breast milk was the sole diet.
• Eight trials compared feeding with preterm formula versus
donor breast milk, either as the sole diet (Tyson 1983; Lucas
1984a; Cristofalo 2013), or as a supplement to maternal breast
milk (Lucas 1984b; Schanler 2005; Corpeleijn 2016; O’Connor
2016; Costa 2018).
The trials varied according to type of donor breast milk, and
whether donor breast milk feeds were nutrient-fortified or not.
• Five trials used donor breast milk collected from mothers
who had delivered an infant at term (Raiha 1976; Davies 1977;
Schultz 1980; Lucas 1984a; Lucas 1984b). Two of these trials
used ’drip’ breast milk (Lucas 1984a; Lucas 1984b). One trial
used preterm donor breast milk (Schanler 2005), one trial used
both term and preterm donor milk (Gross 1983), and five trials
did not specify the type of donor breast milk (Tyson 1983;
Cristofalo 2013; Corpeleijn 2016; O’Connor 2016; Costa
2018).
• In all trials except Tyson 1983, the donor breast milk was
pasteurised.
• Four trials used donor breast milk with multinutrient
fortifier added empirically or as indicated (Schanler 2005;
Cristofalo 2013; Corpeleijn 2016; O’Connor 2016). Cristofalo
2013 used human milk-based fortifier, and the other trials used
cow’s milk-based fortifier.
In general, feeds were allocated for several weeks, or until partici-
pating infants reached a specified body weight (generally > 2 kg).
One trial used the allocated feed for only the first 10 days after
birth (or earlier if the infant was transferred from the recruiting
centre). Infants then received preterm formula if own mother’s
milk was insufficient (Corpeleijn 2016).
Outcomes
The most commonly reported outcomes were growth parameters
during the study period or until hospital discharge. Most reports
gave information on adverse outcomes, including feeding intol-
erance and the incidence of necrotising enterocolitis. Four trials
reported growth or neurodevelopmental outcomes assessed during
and after infancy following hospital discharge (Gross 1983; Lucas
1984a; Lucas 1984b; O’Connor 2016).
Excluded studies
We excluded 14 studies following full-text review (Narayanan
1982; Svenningsen 1982; Jarvenpaa 1983; Cooper 1984; Putet
1984; O’Connor 2003; Sullivan 2010; Hair 2014; Colaizy 2015;
Marseglia 2015; Perrella 2015; Tewari 2018; Brandstetter 2018;
Castellano 2019). The reasons for exclusion are described in the
table Characteristics of excluded studies.
Studies awaiting classification
One report is awaiting translation and assessment (Perez 2015).
Ongoing studies
We identified four ongoing trials (see: Characteristics of ongoing
studies).
Risk of bias in included studies
Quality assessments are detailed in the table Characteristics of
included studies and are illustrated in Figure 2.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
Allocation
Six trials reported adequate allocation concealment methods
(sealed, numbered envelopes; central randomisation in blocks) and
we assessed these trials as being at low risk of bias (Lucas 1984a;
Lucas 1984b; Tyson 1983; Corpeleijn 2016; O’Connor 2016;
Costa 2018). The other trials did not report methods of allocation
concealment. One quasi-RCT randomly allocated participants to
one of the four formula arms, and allocated every fifth infant to
the donor breast milk arm (Raiha 1976); we assessed this trial as
being at high risk of selection bias.
Blinding
Four trials blinded the staff or caregivers to the treatments and we
assessed them as being at low risk of bias (Schanler 2005; Cristofalo
2013; Corpeleijn 2016; O’Connor 2016). Three trials did not
mask the staff and we assessed them as being at high risk of bias
(Tyson 1983; Lucas 1984a; Lucas 1984b). The other trial reports
did not state whether staff were masked.
Most of the trials did not specify whether the outcome assessors
were masked to the feeding arms (unclear risk of bias). In four
trials staff were masked to the post-hospital discharge outcomes
and we assessed them as being at low risk of bias (Lucas 1984a;
Lucas 1984b; Corpeleijn 2016; O’Connor 2016).
Incomplete outcome data
Most trials reported complete follow-up for the in-hospital out-
comes assessment and we assessed them as being at low risk of
attrition bias. In three trials, infants who developed complications
(5% to 10% of the total enrolled) were withdrawn from the study
and therefore the in-hospital growth data for these infants were
not presented (Raiha 1976; Gross 1983; Tyson 1983). In the tri-
als that reported data for long-term outcomes, more than 80% of
participants were assessed (low risk of bias) (Gross 1983; Lucas
1984a; Lucas 1984b; O’Connor 2016).
Selective reporting
We assessed Corpeleijn 2016 as being at high risk of reporting
bias. Corpeleijn 2016 did not report protocol-specified outcome
data for short-term growth rate, bone density, Bayley Scores of
Infant Development III (at 2 years of age), and growth rate at two
years of age. Most of the other trials were at unclear risk of bias as
protocols were not available for assessment.
Effects of interventions
See: Summary of findings for the main comparison Formula
versus donor breast milk for feeding preterm or low birth weight
infants
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Primary outcomes
Growth
Time to regain birth weight
Meta-analysis of data from Raiha 1976, Gross 1983 and Costa
2018 showed that the formula-fed group regained birth weight
more quickly (mean difference (MD) -3.08 days, 95% confidence
interval (CI) -4.38 to -1.77; I² = 37%; 3 trials, 236 participants;
Analysis 1.1).
Schultz 1980 did not detect a statistically significant difference,
but standard deviations (SDs) were not reported and we could not
include the data in the meta-analysis.
Lucas 1984a reported the median time to regain birth weight as
lower in the formula-fed infants (10 versus 16 days). Lucas 1984b
did not find a statistically significant difference (13 versus 15 days).
SDs were not reported and we could not include the data in the
meta-analysis.
The other trials did not report time to regain birth weight.
Rate of weight gain
Formula-fed infants had a higher rate of weight gain but with high
heterogeneity in the estimate of this effect (MD 2.51, 95% CI 1.93
to 3.08 g/kg/day; I² = 90%; 9 trials, 1028 participants; moderate-
certainty evidence; Summary of findings for the main comparison;
Analysis 1.2). Significant subgroup differences existed with the
largest effect size for the comparison of preterm formula with
unfortified donor breast milk (MD 4.16, 95% CI 3.04 to 5.28 g/
kg/day) (Figure 3).
Figure 3. Forest plot of comparison: 1 Formula (term or preterm) versus donor breast milk, outcome: 1.2
Weight gain (g/kg/day).
Schultz 1980 and Corpeleijn 2016 did not report rate of weight
gain.
Costa 2018 did not detect a between-group difference in average
weight at 15 days after birth or at 36 weeks’ post-menstrual age.
Linear growth
Formula-fed infants had a higher rate of increase in crown-heel
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length but with high heterogeneity in the estimate of this effect
(MD 1.21, 95% CI 0.77 to 1.65 mm/week; I² = 68%; 8 trials, 820
participants; moderate-certainty evidence; Summary of findings
for the main comparison; Analysis 1.3; Analysis 1.4; Analysis 1.5).
Significant subgroup differences existed with the largest effect size
for the comparison of preterm formula with unfortified donor
breast milk (MD 2.01, 95% CI 1.21 to 2.81 mm/week) (Figure
4).
Figure 4. Forest plot of comparison: 1 Formula (term or preterm) versus DBM (unfortified of fortified),
outcome: 1.3 Linear growth (crown-heel length mm/week).
14Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Raiha 1976 reported higher rates of increase in crown-rump (MD
0.59, 95% CI 0.08 to 1.10 mm/week) and femoral length (MD
0.34, 95% CI 0.13 to 0.55 mm/week) in the formula-fed group.
Schultz 1980 and Corpeleijn 2016 did not report rate of linear
growth.
Costa 2018 did not detect a between-group difference in average
length at 15 days after birth or at 36 weeks’ post-menstrual age.
Head growth
Formula-fed infants had a higher rate of increase in occipitofrontal
head circumference but with high heterogeneity in the estimate of
this effect (MD 0.85, 95% CI 0.47 to 1.23 mm/week; I² = 74%;
8 trials, 894 participants; moderate-certainty evidence; Summary
of findings for the main comparison; Analysis 1.6). Significant
subgroup differences existed with the largest effect size for the
comparison of preterm formula with unfortified donor breast milk
(MD 4.16, 95% CI 3.04 to 5.28 g/kg/day) (Figure 5).
Figure 5. Forest plot of comparison: 1 Formula (term or preterm) versus DBM (unfortified of fortified),
outcome: 1.6 Head growth (mm/week).
Raiha 1976, Schultz 1980 and Corpeleijn 2016 did not report
rate of head growth.
Costa 2018 did not detect a between-group difference in average
head circumference at 15 days after birth or at 36 weeks’ post-
menstrual age.
Long-term growth
Post-hospital discharge growth was reported by Lucas 1984a and
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Lucas 1984b. Neither individual study, nor meta-analyses of data
from both studies, showed differences in the weight, length or
head circumference at nine months, 18 months or 7.5 to eight
years post-term; Analysis 1.7; Analysis 1.8; Analysis 1.9; Analysis
1.10; Analysis 1.11; Analysis 1.12; Analysis 1.13; Analysis 1.14;
Analysis 1.15.
Neurodevelopment
Death or severe neurodevelopmental disability
These composite data are not yet available from the trials that
assessed neurodevelopmental outcomes.
Neurodevelopmental scores
Four trials have reported neurodevelopmental outcomes or assess-
ment scores in children aged at least 12 months, measured us-
ing validated assessment tools (Gross 1983; Lucas 1984a; Lucas
1984b; O’Connor 2016):
Gross 1983 stated that there was “no difference” in Bayley Mental
or Psychomotor Developmental Indices at 15 months post-term
(numerical data not available).
Lucas 1984a and Lucas 1984b, or a meta-analysis of data from
both, did not show differences in Bayley Psychomotor and Mental
Development Indices at 18 months’ corrected age.
• Mental Development Index: MD 1.24, 95% CI -2.62 to
5.09 (Analysis 1.16).
• Psychomotor Development Index: MD -0.32, 95% CI -
3.48 to 2.79 (Analysis 1.17).
“Severe neurodevelopmental disability” (Amiel-Tison 1986 classi-
fication) was assessed in children aged 18 months post-term in two
trials. Neither Lucas 1984a nor Lucas 1984b, or a meta-analysis of
data from both trials, showed a difference: typical RR 1.21 (95%
CI 0.62 to 2.35; I² = 17%; 2 trials, 400 participants); RD -0.02
(95% CI -0.04 to 0.17); moderate-certainty evidence; Summary
of findings for the main comparison; Analysis 1.18).
O’Connor 2016 did not show any differences in the mean scores
on Bayley Scales of Infant and Toddler Development, Third Edi-
tion (Bayley-III) assessments at 18 to 22 months’ corrected age.
• Cognitive: MD 1.60, 95% CI -2.71 to 5.91 (Analysis 1.19).
• Language: MD 3.00, 95% CI -2.01 to 8.01 (Analysis 1.19).
• Motor: MD 2.20, 95% CI -2.07 to 6.47 (Analysis 1.19).
There were not any differences in the proportion of children with
Bayley-III scores < 70 in O’Connor 2016.
• Cognitive: RR 0.82, 95% CI 0.40 to 1.68 (Analysis 1.20);
RD -0.02, 95% CI -0.08 to 0.05.
• Language: RR 0.78, 95% CI 0.47 to 1.30 (Analysis 1.20);
RD -0.04 (95% CI -0.13 to 0.04).
• Motor: RR 0.73, 95% CI 0.37 to 1.44 (Analysis 1.20); RD
-0.03 (95% CI -0.10 to 0.04).
There were not any differences in the proportion of children di-
agnosed with cerebral palsy, or hearing or visual impairment in
O’Connor 2016.
• Cerebral palsy: RR 0.51, 95% CI 0.21 to 1.23 (Analysis
1.21); RD -0.05 (95% CI -0.10 to 0.01).
• Hearing impairment: RR 1.02, 95% CI 0.30 to 3.45
(Analysis 1.22); RD 0.00 (95% CI -0.04 to 0.04).
• Visual impairment: RR (not estimable - no events; Analysis
1.23); RD 0.00 (95% CI -0.01 to 0.01).
Cognitive and educational outcomes in children aged more
than five years old
Lucas 1984a and Lucas 1984b assessed cognitive outcomes (verbal
and performance intelligence quotient) in about 20% of partici-
pants at ages eight and 16 years. Numerical data were not reported
for the individual trials but rather were combined with data from
another trial undertaken by the same investigators that compared
feeding preterm infants with nutrient-enriched versus standard
formula (Isaacs 2009).
O’Connor 2016 has not yet reported any cognitive and educa-
tional outcomes in children aged more than five years old.
Secondary outcomes
All-cause mortality
Data were available from seven trials. Two trials reported mortality
until nine months post-term (Lucas 1984a; Lucas 1984b). The
other trials reported mortality until hospital discharge (Schanler
2005; Cristofalo 2013; Corpeleijn 2016; O’Connor 2016; Costa
2018). None showed a difference between the groups. Since it
is likely that most infant mortality in this population occurred
before hospital discharge, we combined the data from the trials
in a meta-analysis: RR 1.10, 95% CI 0.80 to 1.50; I² = 0%; 7
trials, 1527 participants; moderate-certainty evidence; Summary
of findings for the main comparison; Analysis 1.24). There were
not any significant subgroup differences (Figure 6).
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Figure 6. Forest plot of comparison: 1 Formula (term or preterm) versus DBM (unfortified of fortified),
outcome: 1.24 All-cause mortality.
Necrotising enterocolitis
Meta-analysis of data available from nine trials showed a higher
risk of necrotising enterocolitis in the formula-fed group: RR 1.87,
95% CI 1.23 to 2.85; I² = 14%; 9 trials, 1675 participants; RD
0.03, 95% CI 0.01 to 0.05; number needed to treat for an ad-
ditional harmful outcome (NNTH) 33 (95% CI 20 to 100);
moderate-certainty evidence; Summary of findings for the main
comparison; Analysis 1.25). There were not any significant sub-
group differences (Figure 7).
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Figure 7. Forest plot of comparison: 1 Formula (term or preterm) versus DBM (unfortified of fortified),
outcome: 1.25 Necrotising enterocolitis.
Days after birth to establish full enteral feeding
This was reported by three trials. A meta-analysis of data from
Cristofalo 2013 and Costa 2018 did not show a difference (MD
0.33, 95% CI -2.57 to 3.23 days; Analysis 1.26). There were not
any significant subgroup differences.
Corpeleijn 2016 reported no difference in median time to full
feeds independent of parenteral nutrition (12 versus 11 days) but
did not provide sufficient data for inclusion in a meta-analysis.
Feeding intolerance
Meta-analysis of data from Gross 1983 and Tyson 1983 showed a
higher incidence of feeding intolerance in the formula-fed group
(RR 4.92, 95% CI 1.17 to 20.70; RD 0.10, 95% CI 0.01 to 0.19;
NNTH 10, 95% CI 5 to 100; Analysis 1.27).
Lucas 1984a reported that significantly more infants in the for-
mula-fed group failed to tolerate full enteral feeds by two weeks
after birth (25/76 versus 9/83 in the donor breast milk group) and
by three weeks after birth (13/76 versus 4/83).
Incidence of invasive infection
Meta-analysis of data available from five trials did not show a
difference in invasive infection (RR 0.94, 95% CI 0.79 to 1.12;
I² = 37%; 5 trials, 1025 infants; Analysis 1.28). There were not
any significant subgroup differences.
Subgroup analysis: formula versus donor breast milk
as (i) sole diet or (ii) supplement to maternal
expressed breast milk
• Seven trials compared feeding with formula versus donor
breast milk as a sole diet (Raiha 1976; Davies 1977; Schultz
1980; Gross 1983; Tyson 1983; Lucas 1984a; Cristofalo 2013).
• Five trials compared feeding with formula versus donor
breast milk as a supplement to maternal expressed breast milk
(Lucas 1984b; Schanler 2005; Corpeleijn 2016; O’Connor
2016; Costa 2018).
Growth
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Meta-analyses did not show subgroup differences for rate of weight
gain (Analysis 2.1), or increase in crown-heel length (Analysis 2.2).
Subgroup comparisons showed significant differences for head
growth.
• Sole diet: MD 1.36, 95% CI 0.85 to 1.88 mm/week.
• Supplement: MD 0.24, 95% CI -0.32 to 0.80 mm/week.
• Test for subgroup differences: Chi² = 8.37, df = 1 (P =
0.004), I² = 88.1% (Analysis 2.3).
Meta-analyses of data from Lucas 1984a (sole diet) and Lucas
1984b (supplemental) did not show any subgroup differences
for long-term growth (Analysis 2.4; Analysis 2.5; Analysis 2.6;
Analysis 2.7; Analysis 2.8; Analysis 2.9; Analysis 2.10; Analysis
2.11; Analysis 2.12).
Neurodevelopment
Meta-analyses of data from Lucas 1984a (sole diet) and Lucas
1984b (supplemental) did not show any subgroup differences
for neurodevelopmental outcomes (Analysis 2.13; Analysis 2.14;
Analysis 2.15).
Secondary outcomes
Meta-analyses did not show significant subgroup differences for
all-cause mortality (Analysis 2.16), or necrotising enterocolitis (
Analysis 2.17).
Subgroup comparisons showed significant differences for inci-
dence of invasive infection.
• Sole diet: RR 1.43, 95% CI 0.97 to 2.11; RD 0.24, 95%
CI -0.00 to 0.48.
• Supplement: RR 0.89, 95% CI 0.73 to 1.08; RD -0.03,
95% CI -0.09 to 0.02.
• Test for subgroup differences: Chi² = 4.70, df = 1 (P =
0.03), I² = 78.7% (Analysis 2.18).
D I S C U S S I O N
Summary of main results
We included 12 randomised controlled trials (RCTs) in which a
total of 1879 preterm or low birth weight (LBW) infants partici-
pated. Meta-analyses show that infants who receive formula regain
birth weight earlier and have higher in-hospital rates of weight
gain, linear growth, and head growth than infants who receive
donor breast milk. These effects on growth parameters are greater
in trials that compare feeding with nutrient-enriched preterm for-
mula rather than standard term formula versus donor breast milk.
Follow-up of the infants who participated in two of the largest
trials did not show any effects on long-term growth. None of the
trials that assessed neurodevelopment beyond infancy showed any
significant effects.
Meta-analysis of data from eight trials shows that feeding with
formula rather than donor breast milk increases the risk of necro-
tising enterocolitis in preterm and LBW infants.
Overall completeness and applicability of
evidence
These findings should be interpreted with caution. Substantial
heterogeneity in the meta-analyses of weight gain, linear growth,
and head growth limits the validity of the pooled estimates of ef-
fect size. Many of the trials that contributed data to these meta-
analyses were undertaken more than 20 years ago and the trials
used different inclusion criteria and varied with respect to the type
of formula and donor breast milk. Five trials have been undertaken
in the past 20 years and four of these trials compared feeding with
preterm formula versus donor breast milk with added multinu-
trient fortifier (Schanler 2005; Cristofalo 2013; Corpeleijn 2016;
O’Connor 2016). Subgroup analyses of data from these trials,
which are more likely to be applicable to current practice in high-
income countries, where nutrient fortification of breast milk is
commonly undertaken, shows higher rates of weight gain and lin-
ear growth in formula-fed infants, but no effect on head growth.
The pooled estimate from meta-analysis of data from nine trials
suggests that one extra case of necrotising enterocolitis will occur
in every 33 infants who receive formula. This beneficial effect of
donor breast milk exists even when donor breast milk is given as
a supplement to maternal breast milk, rather than as a sole diet,
and when the donor breast milk is nutrient-fortified. The sub-
group meta-analysis of four trials that compared feeding infants
with preterm (nutrient-enriched) formula versus nutrient-fortified
donor breast milk was moderately heterogeneous (I² = 51%). A
possible explanation is that the trials differed in the intensity and
duration of exposure to the intervention. Infants participating in
Corpeleijn 2016 (the trial that contributed most to the heterogene-
ity) received the trial interventions for only the first 10 days after
birth as maternal (mother’s own) breast milk was widely available
by this stage. In the other three trials, in contrast, infants received
the allocated intervention for up to 90 days or the duration of
birth hospitalisation (Schanler 2005; Cristofalo 2013; O’Connor
2016). It is plausible that donor breast milk is less effective in pre-
venting necrotising enterocolitis in settings where formula (rather
than maternal breast milk) use is more prevalent.
Most of the trials included in the meta-analysis did not mask
caregivers and assessors to the intervention. This methodological
weakness may have resulted in surveillance and ascertainment bi-
ases that contributed to the higher rate of detection of necrotising
enterocolitis in formula-fed infants. Caution should be exercised
in applying these data to growth-restricted preterm infants or sick
infants since these infants, although at high risk of developing
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necrotising enterocolitis, were ineligible to participate in many of
the included trials.
The data in this review are from trials undertaken in high-income
countries. In low- or middle-incomes countries, the immunoac-
tive properties of breast milk may confer advantages that outweigh
the lower rate of short-term growth. In India, a RCT in LBW in-
fants “at risk of infection” found that serious infections (diarrhoea,
pneumonia, septicaemia) were less common in infants allocated to
received “expressed human milk” versus formula milk (Narayanan
1982). “Expressed human milk” in this study referred to a mixture
of maternal and donor breast milk. As we could not separate these
into subgroups, we did not include the data in the review.
Quality of the evidence
The GRADE certainty of evidence was moderate for rates of
weight gain, linear growth, and head growth (downgraded for
high levels of heterogeneity) and was moderate for neurodevelop-
mental disability, all-cause mortality, and necrotising enterocolitis
(downgraded for imprecision) (Summary of findings for the main
comparison).
Some of the trials contained various weaknesses in methodological
quality, specifically concern about allocation concealment meth-
ods in four trials, and about methods to ensure masking in most
of the trials. Parents, caregivers, clinicians and investigators were
likely to have been aware of the treatment group to which infants
had been allocated and this knowledge may have affected some
care practices or investigation strategies, including thresholds for
screening or diagnosing for necrotising enterocolitis.
Most of the included trials were funded or supported by the man-
ufacturers of the formulas being assessed, but the funders were not
involved in trial design or analysis. There remains some concern
that formula manufacturers may promote study findings of tri-
als of specialist formulas selectively as part of a marketing strat-
egy that subverts UNICEF Baby Friendly Initiative regulations
(Cleminson 2015).
Potential biases in the review process
The main concern with the review process is the possibility that the
findings are subject to publication and other reporting biases, in-
cluding more availability of numerical data for inclusion in meta-
analyses from trials that reported statistically significant or clini-
cally important effects. We attempted to minimise this threat by
screening the reference lists of included trials and related reviews
and searching the proceedings of the major international perinatal
conferences to identify trial reports that are not (or not yet) pub-
lished in full form in academic journals. However, we cannot be
sure whether other trials have been undertaken, but not reported,
and the concern remains that such trials are less likely than pub-
lished trials to have detected statistically significant or clinically
important effects. The meta-analyses that we performed did not
contain sufficient trials to explore symmetry of funnel plots as a
means of identifying possible publication or reporting bias.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is moderate-certainty evidence that feeding with formula,
particularly preterm formula, compared with donor breast milk
increases rates of weight gain, linear growth, and head growth in
preterm or low birth weight (LBW) infants in hospital. Formula
feeding is associated with a near-doubling of the risk of necro-
tising enterocolitis. These is no evidence of an effect on all-cause
mortality, or on long-term growth and neurodevelopment. There
are limited data from RCTs on the comparison of feeding with
formula milk versus nutrient-fortified human milk. This limits
the implications for practice from this review as nutrient fortifi-
cation of human milk is now a common practice in neonatal care
(Williams 2016).
Implications for research
Further RCTs of feeding with formula versus donor breast milk in
situations where the expressed breast milk of the preterm or LBW
infant’s mother is not consistently available are needed. Several
such trials are in progress and these propose to recruit more than
1100 infants in total (Characteristics of ongoing studies). Incorpo-
rating the data from these trials in meta-analyses should generate
more precise estimates of effect sizes, and strengthen the applica-
bility of the trial evidence base to current practice. In addition to
clinical effectiveness, future research efforts to inform practice and
policy should assess acceptability and cost-effectiveness (Buckle
2017).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Corpeleijn 2016
Methods Randomised controlled trial
Participants 373 VLBW infants with insufficient maternal breast milk during the first 10 days after
birth. Six neonatal units in the Netherlands, 2012 to 2014
Interventions Preterm formula (N = 190) versus donor breast milk (N = 183) given as a supplement
to maternal breast milk (with cow’s milk-based multinutrient fortifier)
Outcomes Invasive infection, NEC, or mortality during the first 60 days after birth (composite)
Notes Intervention given during first 10 days after birth only
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Online randomisation software”
Allocation concealment (selection bias) Low risk Computer randomised
Blinding (performance bias and detection
bias)
All outcomes
Low risk Families and clinicians “blinded”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 99% assessment for primary outcome
Selective reporting (reporting bias) High risk Protocol specified short-term growth rate, bone density.
Bayley Scores of Infant Development III (at 2 years of
age), growth rate (at 2 years of age) as outcomes to be
assessed - these are not reported
Other bias Unclear risk Funded by Mead Johnson Nutrition
Costa 2018
Methods Randomised controlled trial
Participants 70 infants (< 33 weeks’) with insufficient maternal breast milk during the first 14 days
after birth. One neonatal unit in Italy, 2015
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Costa 2018 (Continued)
Interventions Preterm formula (N = 35) versus donor breast milk (N = 35) given as a supplement to
maternal breast milk
Outcomes Time to full enteral feeding (150 mL/kg/day), invasive infection, NEC, bronchopul-
monary dysplasia (BPD), or mortality until 36 weeks’ post-menstrual age
Notes Fortification policy not described (author contacted June 2019 for clarification: simon-
etta.costa@policlinicogemelli.it)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer-generated list of random numbers”
Allocation concealment (selection bias) Low risk “...sequence was concealed from researchers”
Blinding (performance bias and detection
bias)
All outcomes
High risk Families and clinicians not masked
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete assessment for primary outcome
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funder not stated
Cristofalo 2013
Methods Randomised controlled trial
Participants 53 newborn infants: birth weight 500 g to 1250 g
Exclusions: major congenital abnormalities, high likelihood of transfer to a non-study
site after 48 hours
Seven neonatal intensive care units: six in USA, one in Austria
(Probably) 2010 to 2012
Interventions Preterm formula milk (N = 24) versus fortified (with human milk-based fortifier), pas-
teurised donor breast milk (N = 29). Assigned until 91 days after birth, or discharge, or
oral feeding at least 50% of feeds
Outcomes Duration of parenteral nutrition, growth, respiratory support, and NEC
Notes Additional information on methods courtesy of Dr Cristafalo (April 2014)
26Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cristofalo 2013 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random sequence generated centrally in permuted
blocks stratified by investigational site
Allocation concealment (selection bias) Low risk Allocation outcome provided to an individual at each site
who was not connected with the evaluation of outcomes
for participants
Blinding (performance bias and detection
bias)
All outcomes
Low risk Investigators, caregivers, and families were masked
Incomplete outcome data (attrition bias)
All outcomes
Low risk 100% follow-up
Selective reporting (reporting bias) Low risk No deviations from protocol
Other bias Unclear risk Funded by Prolacta Bioscience
Davies 1977
Methods Randomised controlled trial
Participants 68 preterm infants: 28 to 36 weeks in 2 strata
Exclusions: multiple births, congenital abnormalities and chromosomal disorders, con-
genital infection. Growth-restricted infants (< 5th percentile) may also have been ex-
cluded
Department of Child Health, University Hospital of Wales, Cardiff
1972 to 1973
Interventions Term formula milk (N = 34) versus unfortified, pasteurised donor breast milk (N = 34)
. Assigned from birth for 2 months
Outcomes Rates of weight gain, increase in head circumference and length from birth until 1 month
and from 1 month until 2 months
Notes Infants of mothers who wished to breastfeed were initially given expressed breast milk
if unable to feed naturally. There were only 2 such infants; their feeding group was not
specified and the results for these infants are not presented separately in the paper. Given
that this applies to only 2 out of 68 infants, we have included this study in the review
Risk of bias
Bias Authors’ judgement Support for judgement
27Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Davies 1977 (Continued)
Random sequence generation (selection
bias)
Unclear risk Method not stated
Allocation concealment (selection bias) Unclear risk Method not stated
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk 100% follow-up
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funder not stated (likely to be unfunded)
Gross 1983
Methods Randomised controlled trial
Participants 67 preterm infants (27 to 33 weeks)
Birth weight < 1600 g. Excluded if “congenital anomaly or major disease”
Department of Pediatrics, Duke University, USA
1980 to 1982
Interventions Term formula milk (N = 26) versus unfortified, pasteurised donor breast milk (N = 41).
Feeds were assigned until the infant reached a weight of 1800 g or until withdrawn from
the study because of feeding intolerance or NEC
Outcomes Time to regain birth weight
Mean daily gain in weight, length and head circumference, from regaining birth weight
until reaching 1800 g
Data on adverse events can be determined, although these were not primary endpoints
of the study
Notes Although the report gave information on adverse outcomes, the 7 affected infants were
withdrawn from the study and not included in the analyses of growth rates. Therefore,
growth data are reported for 20 infants in each arm of the trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table
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Gross 1983 (Continued)
Allocation concealment (selection bias) Unclear risk Method not stated
“Any infant withdrawn from the study was replaced by
the next one enrolled”; implies lack of allocation conceal-
ment for these infants
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 7 out of 67 (10%) with adverse outcomes (NEC, mor-
tality) were not assessed for growth outcomes. This in-
cluded 6/26 (23%) in the formula group and 1/41 (2.
4%) in the donor breast milk group, so potential bias
100% follow-up and low risk of bias for mortality and
NEC
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funded by Mead Johnson Nutrition
Lucas 1984a
Methods Randomised controlled trial
Participants 159 infants of birth weight < 1850 g
Stratified by birth weight < 1200 g and 1201 g to 1850 g
Infants with congenital abnormalities excluded. Infants with intrauterine growth restric-
tion not excluded
Study undertaken in the early 1980s in neonatal units in the Anglia region of the UK
Interventions Preterm formula milk (N = 76) versus donor (mainly “drip”) breast milk (N = 83)
The formula was intended to be delivered at 180 mL/kg/day versus the breast milk at
200 mL/kg/day
Feeds were assigned until the infant reached a weight of 2000 g or until discharge from
the neonatal unit
Outcomes Short-term outcomes:
Time to regain birth weight (62 infants). Rates of change in weight (58 infants), crown-
heel length (26 infants) and head circumference (48 infants) from the point of regained
birth weight until discharge from the neonatal unit or reaching a weight of 2000 g
Incidence of NEC - suspected and confirmed reported on complete cohort of 159 infants
Longer-term outcomes:
Validated neurological assessment at 18 months in 122 (85%) of surviving infants
Bayley Mental Development Index and Psychomotor Development Index at 18 months
post-term, in 114 (94%) of surviving infants suitable for the assessment
Growth performance in surviving infants (weight, length and head circumference) at 9
months (110 infants), 18 months (136 infants) and 7.5 to 8 years (130 infants) post-
term
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Lucas 1984a (Continued)
Notes The first “interim” report provided data on short-term growth outcomes in a predefined
subset of the total cohort recruited.
Follow-up at 18 months was achieved for more than 80% of surviving infants. Devel-
opmental assessments (Bayley Psychomotor and Mental Development Indices) at 18
months post-term were reported for 114 of the 159 children originally enrolled in the
study. 16 children had died and 7 had been lost to follow-up. 12 surviving children had
cerebral palsy affecting fine motor skills and these children were not assessed. A further
10 children were not assessed due to severe visual or hearing impairment or because
follow-up data were obtained by telephone for geographical reasons
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Balanced randomisation sequence was prepared for each
centre, within strata defined by birth weight (method of
sequence generation not stated explicitly)
Allocation concealment (selection bias) Low risk Sealed, numbered envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk 100% assessment of in-hospital outcomes and > 80%
follow-up for long-term outcomes (except for cognitive
outcomes (verbal and performance intelligence quotient)
, which were assessed in about 20% of participants at ages
8 and 16 years)
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funded by Farley Health Products
Lucas 1984b
Methods Randomised controlled trial
Participants 343 infants of birth weight < 1850 g. Stratified by birth weight < 1200 g and 1201 g to
1850 g.
Infants with congenital abnormalities excluded. Infants with intrauterine growth restric-
tion not excluded
Study undertaken in the early 1980s in neonatal units in the Anglia region of the UK
Interventions Preterm formula milk (N = 173) versus banked donor breast milk (N = 170) as a
supplement to the mother’s own breast milk
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Lucas 1984b (Continued)
Outcomes Short-term outcomes: time to regain birth weight (132 infants). Rates of change in weight
(115 infants), crown-heel length (45 infants) and head circumference (97 infants) from
the point of regained birth weight until discharge from the neonatal unit or reaching a
weight of 2000 g
Incidence of NEC - suspected and confirmed reported on complete cohort of 343 infants
Longer-term outcomes:
Validated neurological assessment, at 18 months, in 278 (88%) of surviving infants
Bayley Mental Development Index and Psychomotor Development Index at 18 months,
corrected for preterm gestation, in 273 (96%) of surviving infants suitable for the assess-
ment
Growth performance in surviving infants (weight, length and head circumference) at 9
months (259 infants), 18 months (302 infants) and 7.5 years to 8 years (290 infants)
post-term
Notes The first “interim” report provided data on short-term growth outcomes in a predefined
subset of the total cohort recruited.
Developmental assessments (Bayley Psychomotor and Mental Development Indices) at
18 months post-term were reported for 273 of 343 children originally enrolled in the
study. 29 children had died and 12 had been lost to follow-up. 24 surviving children had
cerebral palsy affecting fine motor skills and these children were not assessed. A further 5
children were not assessed due to severe visual or hearing impairment or because follow-
up data were obtained by telephone for geographical reasons
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated
Allocation concealment (selection bias) Low risk Sealed, numbered envelopes
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk 100% assessment of in-hospital outcomes and > 80%
follow-up for long-term outcomes except for cognitive
outcomes (verbal and performance intelligence quotient)
which were assessed in about 20% of participants at ages
8 and 16 years)
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funded by Farley Health Products
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O’Connor 2016
Methods Randomised controlled trial
Participants 363 VLBW infants whose mothers intended to breastfeed but whose own milk became
insufficient from birth until 90 days of age or hospital discharge
Four neonatal units in Ontario, Canada, 2010 to 2012
Interventions Preterm formula (N = 182) versus donor breast milk (N = 181) given as a supplement
to maternal breast milk (bovine-based multinutrient-fortified)
Outcomes Cognitive composite score on the Bayley Scales of Infant and Toddler Development,
Third Edition (Bayley-III) at 18 months post-term
Bayley-III language and motor composite scores, mortality and morbidity index (late-
onset infection, NEC (Bell stage ≥ II), chronic lung disease, or retinopathy of prematurity
(treated medically or surgically), and growth during the feeding intervention
Notes “A similar percentage of infants in the donor milk group (28.2%) and formula group
(26.9%) were exclusively fed mother’s milk”
“Infants in both groups were fed substantial amounts of maternal milk, with approxi-
mately 25% in each group receiving only maternal milk, and the remainder receiving
about 60% maternal milk”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Computer-driven third-party randomisation service”
Allocation concealment (selection bias) Low risk Computer-randomised
Blinding (performance bias and detection
bias)
All outcomes
Low risk Families and clinicians “blinded”
Incomplete outcome data (attrition bias)
All outcomes
Low risk > 90% assessment for primary outcome
Selective reporting (reporting bias) Low risk No protocol deviations
Other bias Unclear risk Funded by the Canadian Institutes of Health Research
(MOP No. 102638) and the Ontario Ministry of Health
and Long-Term Care (grant No. 06465)
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Raiha 1976
Methods Randomised controlled trial
Participants 106 preterm infants of birth weight < 2100 g, but between 10th and 90th centiles for
birth weight. Infants excluded if evidence of “physical abnormality or obvious disease”
Premature Unit, Helsinki University Children’s Hospital, 1972 to 1975
Interventions Term formula milk (N = 84) versus unfortified donor breast milk (N = 22)
Feeds continued until a weight of 2.4 kg was attained or until infants were withdrawn
from the study because of a “medical complication”
Outcomes Time, from birth, to regain birth weight. Rate of weight gain from birth and from point
of regained birth weight
Notes Donor breast milk was given at a 170 mL/kg/day, compared with formula at 150 mL/
kg/day, “in order to achieve equivalent calorie inputs”. Donor breast milk-fed infants
were given supplemental vitamins
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomly selected permutations of 1, 2, 3, 4 were pre-
pared in advance, which were used to allocate to the 4
formula arms. Every 5th infant was assigned to pooled
breast milk. Hence, it was not strictly random. Also, no
details of how the permutations were generated
Allocation concealment (selection bias) High risk Every 5th infant was assigned to pooled breast milk so
allocation concealment may have been suboptimal
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk 95% follow-up (5/106 infants who were enrolled were
dropped from the study for medical reasons)
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funded by Wyeth Laboratories, the Juselius Foundation,
and the New York State Department of Mental Hygiene
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Schanler 2005
Methods Randomised controlled trial
Participants 173 infants of gestational age < 30 weeks, whose mothers intended to breastfeed but
whose own milk became insufficient from birth until 90 days of age or hospital discharge
North Shore University Hospital, New York, USA, 2000 to 2003
Interventions Preterm formula (N = 81) versus unfortified donor breast milk (N = 92) given as a
supplement to maternal breast milk
Outcomes Incidence of late-onset invasive infection and NEC, duration of hospitalisation and
growth during the study period (weight gain, head circumference increment and length
increment)
Notes Participating infants received small quantities (20 mL/kg/day) of their own mother’s milk
during the first week after birth and continued for 3 to 5 days before the volume was
advanced. Milk intake was increased by 20 mL/kg/day to 100 mL/kg/day at which time
human milk fortifier was added. Subsequently the volume of fortified human milk was
advanced by 20 mL/kg/day until 160 mL/kg/day was achieved. If no mother’s milk was
available and the baby was assigned to donor breast milk then a similar advancement and
fortification protocol was followed. For all infants, adjustments in milk intake between
160 mL/kg/day and 200 mL/kg/day were recommended to ensure an average weekly
weight gain of at least 15 g/kg per day.
17 enrolled infants were switched from donor breast milk to preterm formula because of
poor weight gain but all of these analyses were by intention-to-treat. However, 7 infants
who were never fed (3 in the donor milk group, 4 in the formula group) were excluded
from the analyses
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Method not stated explicitly but very likely to be com-
puter-generated since the random sequence was “an un-
balanced blocked design, according to the stratifica-
tion variables of gestational age and receipt of prenatal
steroids”
Allocation concealment (selection bias) Low risk Allocation was “performed by the research nurse coordi-
nator with sealed opaque envelopes”
Blinding (performance bias and detection
bias)
All outcomes
High risk Unblinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Complete follow-up
Selective reporting (reporting bias) Unclear risk Protocol not available
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Schanler 2005 (Continued)
Other bias Unclear risk Funded by the US National Institute of Child Health
and Human Development and the National Institutes of
Health General Clinical Research Center, Baylor College
of Medicine, USA
Schultz 1980
Methods Randomised controlled trial
Participants 20 preterm or LBW infants; all infants were “physically normal with no further signs of
disease”
Department of Paediatrics, University Medical School, Pecs, Hungary, prior to 1980
Interventions Term formula milk (N = 10) versus donor breast milk (N = 10) for at least 4 weeks from
birth
Outcomes Time, from birth, to regain birth weight (mean but no SD reported)
Mean weight gain from birth and from regaining birth weight calculable from graph but
no SD
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not stated
Allocation concealment (selection bias) Unclear risk No information given
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk 100% follow-up
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funder not stated
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Tyson 1983
Methods Randomised controlled trial
Participants 81 VLBW infants, excluding infants with “any significant illness” or those who required
ventilatory support at day 10
Parklands Memorial Hospital, Dallas, USA, early 1980s
Interventions Preterm formula milk (N = 44) versus donor breast milk (N = 37). The donor breast
milk was not pasteurised. Feeds were allocated on the 10th day of life, and continued
until the infant reached a weight of 2000 g or until withdrawn from the study because
of “any illness requiring intravenous infusion of fat or protein”
Outcomes Mean daily rates of change in weight, crown-heel length and head circumference from
the 10th until the 30th day after birth
Notes The feeds were not allocated until the 10th day after birth in order to avoid the use of
protein-enriched formula “when active growth was unlikely”. In the first 9 days of life the
infants received a term formula or maternal expressed breast milk (if available). Although
the report gave information on adverse outcomes, including NEC, the 5 affected infants
were withdrawn from the study and not included in the analyses of growth rates
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Infants were stratified by birth weight and randomised,
but how the sequence was generated is not stated
Allocation concealment (selection bias) Low risk Concealed envelope opened only after informed parental
consent obtained
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No information given
Incomplete outcome data (attrition bias)
All outcomes
Low risk Five infants with adverse outcomes did not have growth
data
Selective reporting (reporting bias) Unclear risk Protocol not available
Other bias Unclear risk Funded by the Robert Wood Johnson Foundation, by
the University of Texas Health Science Center at Dallas,
and by a grant from Ross Laboratories
LBW: low birth weight
NEC: necrotising enterocolitis
SD: standard deviation
VLBW: very low birth weight
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Brandstetter 2018 Development and proposal of a “decision tree” for prioritising donor breast milk use
Castellano 2019 Retrospective cohort study if impact of the availability of donor human milk
Colaizy 2015 Review article describing ongoing trials by authors, but without outcome data
Cooper 1984 Non-randomised study in preterm infants of feeding with formula or donor breast milk
Hair 2014 Randomised trial of human milk “cream” supplementation in very low birth weight infants
Jarvenpaa 1983 Non-randomised study comparing growth in low birth weight infants fed formula versus breast milk
Marseglia 2015 Randomised trial of a new preterm formula versus another formula, and a “reference” control group of infants
fed with human milk based on maternal preference
Narayanan 1982 Comparative trial in low birth weight infants of feeding with formula milk versus “expressed human milk”.
Many of the infants were allocated to the human milk groups by preference rather than randomly
O’Connor 2003 Non-randomised study comparing growth, feeding tolerance, morbidity and development in low birth weight
infants fed human milk or formula
Perrella 2015 Non-randomised study of gastric emptying rates in infants fed with fortified versus non-fortified human milk
Putet 1984 Non-randomised study of feeding very preterm infants with pooled human milk versus formula
Sullivan 2010 Randomised controlled trial of feeding very low birth weight infants with formula plus bovine milk-based fortifier
versus donor human milk plus human milk-based fortifier; excluded because type of fortifier was cointervention
Svenningsen 1982 Randomised trial of two different formulas versus breast milk in low birth weight infants- most infants in the
breast milk group received their own mother’s expressed milk rather than donor breast milk (not randomised)
Tewari 2018 Randomised trial of early versus late feeding of very preterm infants with maternal or donor breast milk
Characteristics of studies awaiting assessment [ordered by study ID]
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Perez 2015
Methods Quasi-randomised controlled trial
Participants 200 low birth weight infants with insufficient maternal breast milk from birth to three weeks or until hospital
discharge
Neonatal units in San Carlos, Guatemala, 2012 to 2013
Interventions Preterm formula (N = 100) versus donor breast milk (N = 100) given as a supplement to maternal breast milk
(unfortified)
Outcomes Growth parameters for three weeks
Necrotising enterocolitis (unclear how defined)
Notes Awaiting further information from authors regarding methods and findings
Characteristics of ongoing studies [ordered by study ID]
NCT01232725
Trial name or title Donor human milk and neurodevelopmental outcomes in very low birthweight (VLBW) infants
Methods Randomised controlled trial
Participants 121 very low birth weight infants
Two neonatal units in USA (2009-15)
Interventions Donor human milk (obtained from the Mother’s Milk of Iowa), “fortified as appropriate” versus preterm
formula
Outcomes Primary: Bayley Scales of Infant Development, III scores (18 to 22 months’ adjusted age)
Starting date 2009
Contact information Tarah Colaizy: tarah-colaizy@uiowa.edu
Notes Awaiting publication (preliminary data available from author but not yet sufficiently complete for inclusion)
ClinicalTrials.gov Identifier: NCT01232725
NCT01390753
Trial name or title Role of human milk bank in the protection of severe respiratory disease in very low birth weight premature
infants
Methods Randomised controlled trial
Participants 300 very low birth weight infants
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NCT01390753 (Continued)
Interventions Donor breast milk and preterm formula versus preterm formula alone
Outcomes Incidence of respiratory infections in infancy
Starting date 2012
Contact information Fernando Pedro Polack: malinez@infant.org.ar
Notes www.clinicaltrials.gov/ct2/show/NCT01390753
NCT01534481
Trial name or title Donor milk vs. formula in extremely low birth weight (ELBW) infants (the MILK trial)
Methods Randomised controlled trial
Participants 670 extremely low birth weight infants
Interventions Donor breast milk (provided by the Human Milk Banking Association of North America) versus preterm
formula
Outcomes Primary: Bayley Scales of Infant Development III (BSID III) at 22 to 26 months post-term
Starting date 2012 (estimated completion 2018)
Contact information Tarah Colaizy: tarah-colaizy@uiowa.edu
Notes Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) - sponsored
in 17 centres, USA
www.clinicaltrials.gov/ct2/show/NCT01534481?term=breast+milk&cond=weight&rank=5
NCT01686477
Trial name or title PREterM FOrmula Or Donor breast milk for premature babies (PREMFOOD)
Methods Randomised controlled trial (3 arms)
Participants 66 very preterm infants
Interventions Donor breast milk or donor breast milk with fortifier or preterm formula
Outcomes Primary: total body adiposity measured by magnetic resonance imaging (MRI) at “term equivalent”
Starting date 2012
Contact information Luke Mills: l.mills@imperial.ac.uk
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NCT01686477 (Continued)
Notes www.clinicaltrials.gov/ct2/show/NCT01686477
40Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Time to regain birth weight
(days from birth)
3 236 Mean Difference (IV, Fixed, 95% CI) -3.08 [-4.38, -1.77]
1.1 Term formula versus
unfortified DBM
2 166 Mean Difference (IV, Fixed, 95% CI) -2.00 [-5.81, -2.18]
1.2 Preterm formula versus
unfortified DBM
1 70 Mean Difference (IV, Fixed, 95% CI) -2.10 [-3.97, -0.23]
2 Weight gain (g/kg/day) 9 1028 Mean Difference (IV, Fixed, 95% CI) 2.51 [1.93, 3.08]
2.1 Term formula versus
unfortified DBM
3 234 Mean Difference (IV, Fixed, 95% CI) 1.74 [0.96, 2.53]
2.2 Preterm formula versus
unfortified DBM
3 249 Mean Difference (IV, Fixed, 95% CI) 4.16 [3.04, 5.28]
2.3 Preterm formula versus
fortified DBM
3 545 Mean Difference (IV, Fixed, 95% CI) 2.37 [1.09, 3.65]
3 Linear growth (crown-heel
length mm/week)
8 820 Mean Difference (IV, Fixed, 95% CI) 1.21 [0.77, 1.65]
3.1 Term formula versus
unfortified DBM
2 128 Mean Difference (IV, Fixed, 95% CI) 0.80 [0.10, 1.50]
3.2 Preterm formula versus
unfortified DBM
3 147 Mean Difference (IV, Fixed, 95% CI) 1.96 [1.10, 2.82]
3.3 Preterm formula versus
fortified DBM
3 545 Mean Difference (IV, Fixed, 95% CI) 1.10 [0.33, 1.87]
4 Linear growth (crown-rump
length mm/week)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Term formula versus
unfortified DBM
1 106 Mean Difference (IV, Fixed, 95% CI) 0.59 [0.08, 1.10]
5 Linear growth (femoral length
mm/week)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Term formula versus
unfortified DBM
1 106 Mean Difference (IV, Fixed, 95% CI) 0.34 [0.13, 0.55]
6 Head growth (mm/week) 8 894 Mean Difference (IV, Fixed, 95% CI) 0.85 [0.47, 1.23]
6.1 Term formula versus
unfortified DBM
2 128 Mean Difference (IV, Fixed, 95% CI) 0.81 [0.15, 1.47]
6.2 Preterm formula versus
unfortified DBM
3 221 Mean Difference (IV, Fixed, 95% CI) 2.01 [1.21, 2.81]
6.3 Preterm formula versus
fortified DBM
3 545 Mean Difference (IV, Fixed, 95% CI) 0.30 [-0.27, 0.86]
7 Weight (kg) at 9 months
post-term
2 369 Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.26, 0.21]
7.1 Preterm formula versus
unfortified DBM
2 369 Mean Difference (IV, Fixed, 95% CI) -0.03 [-0.26, 0.21]
8 Length (cm) at 9 months
post-term
2 369 Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.64, 0.70]
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8.1 Preterm formula versus
unfortified DBM
2 369 Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.64, 0.70]
9 Head circumference (cm) at 9
months post-term
2 369 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.13, 0.53]
9.1 Preterm formula versus
unfortified DBM
2 369 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.13, 0.53]
10 Weight (kg) at 18 months
post-term
2 438 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.15, 0.35]
10.1 Preterm formula versus
unfortified DBM
2 438 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.15, 0.35]
11 Length (cm) at 18 months
post-term
2 438 Mean Difference (IV, Fixed, 95% CI) 0.53 [-0.15, 1.20]
11.1 Preterm formula versus
unfortified DBM
2 438 Mean Difference (IV, Fixed, 95% CI) 0.53 [-0.15, 1.20]
12 Head circumference (cm) at 18
months post-term
2 438 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.19, 0.39]
12.1 Preterm formula versus
unfortified DBM
2 438 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.19, 0.39]
13 Weight (kg) at 7.5 to 8 years of
age
2 420 Mean Difference (IV, Fixed, 95% CI) -0.56 [-1.42, 0.29]
13.1 Preterm formula versus
unfortified DBM
2 420 Mean Difference (IV, Fixed, 95% CI) -0.56 [-1.42, 0.29]
14 Length (cm) at 7.5 to 8 years of
age
2 420 Mean Difference (IV, Fixed, 95% CI) 0.05 [-1.12, 1.23]
14.1 Preterm formula versus
unfortified DBM
2 420 Mean Difference (IV, Fixed, 95% CI) 0.05 [-1.12, 1.23]
15 Head circumference (cm) at
7.5 to 8 years of age
2 420 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.54, 0.16]
15.1 Preterm formula versus
unfortified DBM
2 420 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.54, 0.16]
16 Bayley Mental Development
Index at 18 months
2 387 Mean Difference (IV, Fixed, 95% CI) 1.24 [-2.62, 5.09]
16.1 Preterm formula versus
unfortified DBM
2 387 Mean Difference (IV, Fixed, 95% CI) 1.24 [-2.62, 5.09]
17 Bayley Psychomotor
Development Index at 18
months
2 387 Mean Difference (IV, Fixed, 95% CI) -0.32 [-3.43, 2.79]
17.1 Preterm formula versus
unfortified DBM
2 387 Mean Difference (IV, Fixed, 95% CI) -0.32 [-3.43, 2.79]
18 Neurodevelopmental disability
at 18 months
2 400 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.62, 2.35]
18.1 Preterm formula versus
unfortified DBM
2 400 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.62, 2.35]
19 Bayley-III 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
19.1 Cognitive 1 299 Mean Difference (IV, Fixed, 95% CI) 1.60 [-2.71, 5.91]
19.2 Language 1 299 Mean Difference (IV, Fixed, 95% CI) 3.0 [-2.01, 8.01]
19.3 Motor 1 299 Mean Difference (IV, Fixed, 95% CI) 2.20 [-2.07, 6.47]
20 Bayley-III score < 70 1 890 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.55, 1.11]
20.1 Cognitive 1 299 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.40, 1.68]
20.2 Language 1 295 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.47, 1.30]
20.3 Motor 1 296 Risk Ratio (M-H, Fixed, 95% CI) 0.73 [0.37, 1.44]
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21 Cerebral palsy 1 299 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.21, 1.23]
22 Hearing impairment 1 299 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.30, 3.45]
23 Visual impairment 1 299 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
24 All-cause mortality 7 1527 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.80, 1.50]
24.1 Preterm formula versus
unfortified DBM
3 572 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.70, 2.14]
24.2 Preterm formula versus
fortified DBM
4 955 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.71, 1.52]
25 Necrotising enterocolitis 9 1675 Risk Ratio (M-H, Fixed, 95% CI) 1.87 [1.23, 2.85]
25.1 Term formula versus
unfortified DBM
1 67 Risk Ratio (M-H, Fixed, 95% CI) 4.73 [0.52, 43.09]
25.2 Preterm formula versus
unfortified DBM
4 653 Risk Ratio (M-H, Fixed, 95% CI) 2.99 [0.90, 9.87]
25.3 Preterm formula versus
fortified DBM
4 955 Risk Ratio (M-H, Fixed, 95% CI) 1.64 [1.03, 2.61]
26 Days after birth to establish full
enteral feeding
2 123 Mean Difference (IV, Fixed, 95% CI) 0.33 [-2.57, 3.23]
26.1 Preterm formula versus
unfortified DBM
1 70 Mean Difference (IV, Fixed, 95% CI) -0.5 [-3.66, 2.66]
26.2 Preterm formula versus
fortified DBM
1 53 Mean Difference (IV, Fixed, 95% CI) 4.70 [-2.56, 11.96]
27 Feeding intolerance or
diarrhoea
2 148 Risk Difference (M-H, Fixed, 95% CI) 0.10 [0.01, 0.19]
27.1 Term formula versus
unfortified DBM
1 67 Risk Difference (M-H, Fixed, 95% CI) 0.21 [0.04, 0.38]
27.2 Preterm formula versus
unfortified DBM
1 81 Risk Difference (M-H, Fixed, 95% CI) 0.02 [-0.06, 0.10]
28 Invasive infection 5 1025 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.79, 1.12]
28.1 Preterm formula versus
unfortified DBM
1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.4 [0.08, 1.93]
28.2 Preterm formula versus
fortified DBM
4 955 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.80, 1.14]
Comparison 2. Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a
supplement to maternal expressed breast milk
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Weight gain (g/kg/day) 9 Mean Difference (IV, Fixed, 95% CI) Subtotals only
1.1 Sole diet 6 421 Mean Difference (IV, Fixed, 95% CI) 2.65 [1.94, 3.36]
1.2 Supplement 3 607 Mean Difference (IV, Fixed, 95% CI) 2.22 [1.23, 3.21]
2 Linear growth (crown-heel
length mm/week)
8 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Sole diet 5 283 Mean Difference (IV, Fixed, 95% CI) 1.54 [0.98, 2.11]
2.2 Supplement 3 537 Mean Difference (IV, Fixed, 95% CI) 0.67 [-0.04, 1.38]
3 Head growth (mm/week) 8 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Sole diet 5 305 Mean Difference (IV, Fixed, 95% CI) 1.36 [0.85, 1.88]
3.2 Supplement 3 589 Mean Difference (IV, Fixed, 95% CI) 0.24 [-0.32, 0.80]
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4 Weight (kg) at 9 months
post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Sole diet 1 110 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.27, 0.67]
4.2 Supplement 1 259 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.37, 0.17]
5 Length (cm) at 9 months
post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 Sole diet 1 110 Mean Difference (IV, Fixed, 95% CI) 0.40 [-0.93, 1.73]
5.2 Supplement 1 259 Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.88, 0.68]
6 Head circumference (cm) at 9
months post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 Sole diet 1 110 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.45, 0.85]
6.2 Supplement 1 259 Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.18, 0.58]
7 Weight (kg) at 18 months
post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 Sole diet 1 136 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.37, 0.57]
7.2 Supplement 1 302 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.19, 0.39]
8 Length (cm) at 18 months
post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Sole diet 1 136 Mean Difference (IV, Fixed, 95% CI) 0.60 [-0.68, 1.88]
8.2 Supplement 1 302 Mean Difference (IV, Fixed, 95% CI) 0.5 [-0.29, 1.29]
9 Head circumference (cm) at 18
months post-term
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 Sole diet 1 136 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.44, 0.64]
9.2 Supplement 1 302 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.25, 0.45]
10 Weight (kg) at 7.5 to 8 years of
age
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 Sole diet 1 130 Mean Difference (IV, Fixed, 95% CI) 0.5 [-1.24, 2.24]
10.2 Supplement 1 290 Mean Difference (IV, Fixed, 95% CI) -0.90 [-1.88, 0.08]
11 Length (cm) at 7.5 to 8 years of
age
2 420 Mean Difference (IV, Fixed, 95% CI) 0.05 [-1.12, 1.23]
11.1 Sole diet 1 130 Mean Difference (IV, Fixed, 95% CI) 1.0 [-1.26, 3.26]
11.2 Supplement 1 290 Mean Difference (IV, Fixed, 95% CI) -0.30 [-1.68, 1.08]
12 Head circumference (cm) at
7.5 to 8 years of age
2 420 Mean Difference (IV, Fixed, 95% CI) -0.19 [-0.54, 0.16]
12.1 Sole diet 1 130 Mean Difference (IV, Fixed, 95% CI) 0.10 [-0.56, 0.76]
12.2 Supplement 1 290 Mean Difference (IV, Fixed, 95% CI) -0.30 [-0.71, 0.11]
13 Bayley Mental Development
Index at 18 months
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
13.1 Sole diet 1 114 Mean Difference (IV, Fixed, 95% CI) 0.5 [-6.21, 7.21]
13.2 Supplement 1 273 Mean Difference (IV, Fixed, 95% CI) 1.60 [-3.11, 6.31]
14 Bayley Psychomotor
Development Index at 18
months
2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
14.1 Sole diet 1 114 Mean Difference (IV, Fixed, 95% CI) 1.20 [-4.38, 6.78]
14.2 Supplement 1 273 Mean Difference (IV, Fixed, 95% CI) -1.0 [-4.74, 2.74]
15 Neurodevelopmental disability
at 18 months
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
15.1 Sole diet 1 122 Risk Ratio (M-H, Fixed, 95% CI) 2.06 [0.64, 6.68]
15.2 Supplement 1 278 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.40, 2.10]
16 All-cause mortality 7 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
16.1 Sole diet 2 212 Risk Ratio (M-H, Fixed, 95% CI) 1.70 [0.71, 4.07]
16.2 Supplement 5 1315 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.73, 1.44]
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17 Necrotising enterocolitis 9 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
17.1 Sole diet 4 360 Risk Ratio (M-H, Fixed, 95% CI) 4.62 [1.47, 14.56]
17.2 Supplement 5 1315 Risk Ratio (M-H, Fixed, 95% CI) 1.56 [0.98, 2.47]
18 Incidence of invasive infection 5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
18.1 Sole diet 1 53 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [0.97, 2.11]
18.2 Supplement 4 972 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.73, 1.08]
Analysis 1.1. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 1 Time to regain birth weight (days from birth).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 1 Time to regain birth weight (days from birth)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Gross 1983 20 10.3 (3.6) 40 15.1 (5.6) 30.8 % -4.80 [ -7.15, -2.45 ]
Raiha 1976 84 13.5 (5.3) 22 16.3 (6.3) 20.6 % -2.80 [ -5.67, 0.07 ]
Subtotal (95% CI) 104 62 51.4 % -4.00 [ -5.81, -2.18 ]
Heterogeneity: Chi2 = 1.12, df = 1 (P = 0.29); I2 =11%
Test for overall effect: Z = 4.32 (P = 0.000016)
2 Preterm formula versus unfortified DBM
Costa 2018 35 12.9 (2.6) 35 15 (5) 48.6 % -2.10 [ -3.97, -0.23 ]
Subtotal (95% CI) 35 35 48.6 % -2.10 [ -3.97, -0.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.20 (P = 0.027)
Total (95% CI) 139 97 100.0 % -3.08 [ -4.38, -1.77 ]
Heterogeneity: Chi2 = 3.16, df = 2 (P = 0.21); I2 =37%
Test for overall effect: Z = 4.63 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.04, df = 1 (P = 0.15), I2 =51%
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Analysis 1.2. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 2 Weight gain (g/kg/day).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 2 Weight gain (g/kg/day)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Davies 1977 34 14.7 (4.7) 34 13 (5.4) 5.7 % 1.70 [ -0.71, 4.11 ]
Gross 1983 20 20.4 (2.7) 40 14.9 (3.2) 13.9 % 5.50 [ 3.96, 7.04 ]
Raiha 1976 84 13.8 (2.5) 22 13.6 (2) 33.7 % 0.20 [ -0.79, 1.19 ]
Subtotal (95% CI) 138 96 53.4 % 1.74 [ 0.96, 2.53 ]
Heterogeneity: Chi2 = 32.04, df = 2 (P<0.00001); I2 =94%
Test for overall effect: Z = 4.33 (P = 0.000015)
2 Preterm formula versus unfortified DBM
Lucas 1984a 30 18 (6) 28 12.8 (2.6) 6.0 % 5.20 [ 2.85, 7.55 ]
Lucas 1984b 56 16.3 (4.5) 59 14.3 (3.1) 16.5 % 2.00 [ 0.58, 3.42 ]
Tyson 1983 42 24.3 (8.2) 34 12.4 (4.8) 3.8 % 11.90 [ 8.94, 14.86 ]
Subtotal (95% CI) 128 121 26.3 % 4.16 [ 3.04, 5.28 ]
Heterogeneity: Chi2 = 35.94, df = 2 (P<0.00001); I2 =94%
Test for overall effect: Z = 7.25 (P < 0.00001)
3 Preterm formula versus fortified DBM
Cristofalo 2013 24 17 (7.1) 29 15 (5.8) 2.7 % 2.00 [ -1.54, 5.54 ]
O’Connor 2016 162 25.5 (9.7) 164 23.9 (10) 7.3 % 1.60 [ -0.54, 3.74 ]
Schanler 2005 88 20.1 (6.7) 78 17.1 (5) 10.4 % 3.00 [ 1.21, 4.79 ]
Subtotal (95% CI) 274 271 20.3 % 2.37 [ 1.09, 3.65 ]
Heterogeneity: Chi2 = 1.02, df = 2 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 3.63 (P = 0.00028)
Total (95% CI) 540 488 100.0 % 2.51 [ 1.93, 3.08 ]
Heterogeneity: Chi2 = 80.95, df = 8 (P<0.00001); I2 =90%
Test for overall effect: Z = 8.52 (P < 0.00001)
Test for subgroup differences: Chi2 = 11.95, df = 2 (P = 0.00), I2 =83%
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Analysis 1.3. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 3 Linear growth (crown-heel length mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 3 Linear growth (crown-heel length mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Davies 1977 34 9.3 (2) 34 8.5 (2.4) 17.7 % 0.80 [ -0.25, 1.85 ]
Gross 1983 20 7.2 (1.8) 40 6.4 (1.6) 22.5 % 0.80 [ -0.13, 1.73 ]
Subtotal (95% CI) 54 74 40.2 % 0.80 [ 0.10, 1.50 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 2.25 (P = 0.024)
2 Preterm formula versus unfortified DBM
Lucas 1984a 12 9.7 (2.2) 14 7.3 (2.4) 6.2 % 2.40 [ 0.63, 4.17 ]
Lucas 1984b 20 9.6 (2.2) 25 8.4 (1.4) 15.9 % 1.20 [ 0.09, 2.31 ]
Tyson 1983 42 11 (4) 34 7 (5) 4.6 % 4.00 [ 1.93, 6.07 ]
Subtotal (95% CI) 74 73 26.6 % 1.96 [ 1.10, 2.82 ]
Heterogeneity: Chi2 = 5.77, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 4.49 (P < 0.00001)
3 Preterm formula versus fortified DBM
Cristofalo 2013 24 11.2 (2.8) 29 8.4 (2.1) 10.6 % 2.80 [ 1.44, 4.16 ]
O’Connor 2016 162 10.7 (4.6) 164 10.1 (4.5) 20.0 % 0.60 [ -0.39, 1.59 ]
Schanler 2005 88 10 (10) 78 12 (8) 2.6 % -2.00 [ -4.74, 0.74 ]
Subtotal (95% CI) 274 271 33.2 % 1.10 [ 0.33, 1.87 ]
Heterogeneity: Chi2 = 11.93, df = 2 (P = 0.003); I2 =83%
Test for overall effect: Z = 2.81 (P = 0.0049)
Total (95% CI) 402 418 100.0 % 1.21 [ 0.77, 1.65 ]
Heterogeneity: Chi2 = 22.05, df = 7 (P = 0.002); I2 =68%
Test for overall effect: Z = 5.36 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.35, df = 2 (P = 0.11), I2 =54%
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Analysis 1.4. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 4 Linear growth (crown-rump length mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 4 Linear growth (crown-rump length mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Raiha 1976 84 5.34 (1.81) 22 4.75 (0.81) 100.0 % 0.59 [ 0.08, 1.10 ]
Subtotal (95% CI) 84 22 100.0 % 0.59 [ 0.08, 1.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.25 (P = 0.025)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 5 Linear growth (femoral length mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 5 Linear growth (femoral length mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Raiha 1976 84 1.97 (0.46) 22 1.63 (0.44) 100.0 % 0.34 [ 0.13, 0.55 ]
Subtotal (95% CI) 84 22 100.0 % 0.34 [ 0.13, 0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.20 (P = 0.0014)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 6 Head growth (mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 6 Head growth (mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Term formula versus unfortified DBM
Davies 1977 34 7.4 (1.6) 34 6.8 (2) 19.3 % 0.60 [ -0.26, 1.46 ]
Gross 1983 20 8.8 (2.2) 40 7.7 (1.1) 13.7 % 1.10 [ 0.08, 2.12 ]
Subtotal (95% CI) 54 74 33.0 % 0.81 [ 0.15, 1.47 ]
Heterogeneity: Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 2.40 (P = 0.016)
2 Preterm formula versus unfortified DBM
Lucas 1984a 25 11 (3.6) 23 8.6 (2.7) 4.5 % 2.40 [ 0.61, 4.19 ]
Lucas 1984b 43 10.1 (2.9) 54 9.4 (2.7) 11.3 % 0.70 [ -0.43, 1.83 ]
Tyson 1983 42 12 (2) 34 8 (4) 6.6 % 4.00 [ 2.53, 5.47 ]
Subtotal (95% CI) 110 111 22.3 % 2.01 [ 1.21, 2.81 ]
Heterogeneity: Chi2 = 12.37, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 4.93 (P < 0.00001)
3 Preterm formula versus fortified DBM
Cristofalo 2013 24 8.8 (1.8) 29 7.8 (2.6) 10.1 % 1.00 [ -0.19, 2.19 ]
O’Connor 2016 162 8.3 (2.9) 164 8.2 (3.2) 32.5 % 0.10 [ -0.56, 0.76 ]
Schanler 2005 88 9 (8) 78 9 (9) 2.1 % 0.0 [ -2.60, 2.60 ]
Subtotal (95% CI) 274 271 44.8 % 0.30 [ -0.27, 0.86 ]
Heterogeneity: Chi2 = 1.73, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.04 (P = 0.30)
Total (95% CI) 438 456 100.0 % 0.85 [ 0.47, 1.23 ]
Heterogeneity: Chi2 = 26.42, df = 7 (P = 0.00042); I2 =74%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Chi2 = 11.78, df = 2 (P = 0.00), I2 =83%
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Analysis 1.7. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 7 Weight (kg) at 9 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 7 Weight (kg) at 9 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 48 7.9 (1.3) 62 7.7 (1.2) 24.2 % 0.20 [ -0.27, 0.67 ]
Lucas 1984b 126 7.9 (1.1) 133 8 (1.1) 75.8 % -0.10 [ -0.37, 0.17 ]
Total (95% CI) 174 195 100.0 % -0.03 [ -0.26, 0.21 ]
Heterogeneity: Chi2 = 1.17, df = 1 (P = 0.28); I2 =14%
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 8 Length (cm) at 9 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 8 Length (cm) at 9 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 48 69.2 (3.7) 62 68.8 (3.3) 25.6 % 0.40 [ -0.93, 1.73 ]
Lucas 1984b 126 69.4 (3.2) 133 69.5 (3.2) 74.4 % -0.10 [ -0.88, 0.68 ]
Total (95% CI) 174 195 100.0 % 0.03 [ -0.64, 0.70 ]
Heterogeneity: Chi2 = 0.40, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.08 (P = 0.94)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 9 Head circumference (cm) at 9 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 9 Head circumference (cm) at 9 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 48 45.3 (1.8) 62 45.1 (1.6) 25.5 % 0.20 [ -0.45, 0.85 ]
Lucas 1984b 126 45.7 (1.6) 133 45.5 (1.5) 74.5 % 0.20 [ -0.18, 0.58 ]
Total (95% CI) 174 195 100.0 % 0.20 [ -0.13, 0.53 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 1.20 (P = 0.23)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 10 Weight (kg) at 18 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 10 Weight (kg) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 64 10 (1.3) 72 9.9 (1.5) 28.0 % 0.10 [ -0.37, 0.57 ]
Lucas 1984b 153 10.1 (1.3) 149 10 (1.3) 72.0 % 0.10 [ -0.19, 0.39 ]
Total (95% CI) 217 221 100.0 % 0.10 [ -0.15, 0.35 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 11 Length (cm) at 18 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 11 Length (cm) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 64 79.3 (3.7) 72 78.7 (3.9) 27.7 % 0.60 [ -0.68, 1.88 ]
Lucas 1984b 153 79.5 (3.8) 149 79 (3.2) 72.3 % 0.50 [ -0.29, 1.29 ]
Total (95% CI) 217 221 100.0 % 0.53 [ -0.15, 1.20 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.54 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 12 Head circumference (cm) at 18 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 12 Head circumference (cm) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 64 47.7 (1.5) 72 47.6 (1.7) 29.7 % 0.10 [ -0.44, 0.64 ]
Lucas 1984b 153 48.2 (1.6) 149 48.1 (1.5) 70.3 % 0.10 [ -0.25, 0.45 ]
Total (95% CI) 217 221 100.0 % 0.10 [ -0.19, 0.39 ]
Heterogeneity: Chi2 = 0.0, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 13 Weight (kg) at 7.5 to 8 years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 13 Weight (kg) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 62 22.3 (5.1) 68 21.8 (5) 24.2 % 0.50 [ -1.24, 2.24 ]
Lucas 1984b 151 22.3 (3.6) 139 23.2 (4.8) 75.8 % -0.90 [ -1.88, 0.08 ]
Total (95% CI) 213 207 100.0 % -0.56 [ -1.42, 0.29 ]
Heterogeneity: Chi2 = 1.89, df = 1 (P = 0.17); I2 =47%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 14 Length (cm) at 7.5 to 8 years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 14 Length (cm) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 62 120.4 (6.6) 68 119.4 (6.5) 27.3 % 1.00 [ -1.26, 3.26 ]
Lucas 1984b 151 121.3 (6.4) 139 121.6 (5.6) 72.7 % -0.30 [ -1.68, 1.08 ]
Total (95% CI) 213 207 100.0 % 0.05 [ -1.12, 1.23 ]
Heterogeneity: Chi2 = 0.93, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 15 Head circumference (cm) at 7.5 to 8 years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 15 Head circumference (cm) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 62 51.9 (1.5) 68 51.8 (2.3) 28.2 % 0.10 [ -0.56, 0.76 ]
Lucas 1984b 151 52.2 (1.9) 139 52.5 (1.7) 71.8 % -0.30 [ -0.71, 0.11 ]
Total (95% CI) 213 207 100.0 % -0.19 [ -0.54, 0.16 ]
Heterogeneity: Chi2 = 1.01, df = 1 (P = 0.32); I2 =1%
Test for overall effect: Z = 1.05 (P = 0.30)
Test for subgroup differences: Not applicable
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Analysis 1.16. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 16 Bayley Mental Development Index at 18 months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 16 Bayley Mental Development Index at 18 months
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 52 95.3 (19.5) 62 94.8 (16.5) 33.0 % 0.50 [ -6.21, 7.21 ]
Lucas 1984b 139 103.8 (20) 134 102.2 (19.7) 67.0 % 1.60 [ -3.11, 6.31 ]
Total (95% CI) 191 196 100.0 % 1.24 [ -2.62, 5.09 ]
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 17 Bayley Psychomotor Development Index at 18 months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 17 Bayley Psychomotor Development Index at 18 months
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 52 94.2 (15.9) 62 93 (14.2) 31.0 % 1.20 [ -4.38, 6.78 ]
Lucas 1984b 139 94.5 (16.5) 134 95.5 (15) 69.0 % -1.00 [ -4.74, 2.74 ]
Total (95% CI) 191 196 100.0 % -0.32 [ -3.43, 2.79 ]
Heterogeneity: Chi2 = 0.41, df = 1 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 18 Neurodevelopmental disability at 18 months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 18 Neurodevelopmental disability at 18 months
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Lucas 1984a 7/56 4/66 25.2 % 2.06 [ 0.64, 6.68 ]
Lucas 1984b 10/138 11/140 74.8 % 0.92 [ 0.40, 2.10 ]
Total (95% CI) 194 206 100.0 % 1.21 [ 0.62, 2.35 ]
Total events: 17 (Formula milk), 15 (Donor breast milk)
Heterogeneity: Chi2 = 1.21, df = 1 (P = 0.27); I2 =17%
Test for overall effect: Z = 0.56 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 19 Bayley-III.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 19 Bayley-III
Study or subgroup Formula Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Cognitive
O’Connor 2016 148 94.5 (18.9) 151 92.9 (19.1) 100.0 % 1.60 [ -2.71, 5.91 ]
Subtotal (95% CI) 148 151 100.0 % 1.60 [ -2.71, 5.91 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
2 Language
O’Connor 2016 148 90.3 (22.3) 151 87.3 (21.9) 100.0 % 3.00 [ -2.01, 8.01 ]
Subtotal (95% CI) 148 151 100.0 % 3.00 [ -2.01, 8.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.17 (P = 0.24)
3 Motor
O’Connor 2016 148 94 (18.6) 151 91.8 (19.1) 100.0 % 2.20 [ -2.07, 6.47 ]
Subtotal (95% CI) 148 151 100.0 % 2.20 [ -2.07, 6.47 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Chi2 = 0.17, df = 2 (P = 0.92), I2 =0.0%
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Analysis 1.20. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 20 Bayley-III score < 70.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 20 Bayley-III score < 70
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Cognitive
O’Connor 2016 12/148 15/151 24.2 % 0.82 [ 0.40, 1.68 ]
Subtotal (95% CI) 148 151 24.2 % 0.82 [ 0.40, 1.68 ]
Total events: 12 (Formula milk), 15 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
2 Language
O’Connor 2016 22/145 29/150 46.6 % 0.78 [ 0.47, 1.30 ]
Subtotal (95% CI) 145 150 46.6 % 0.78 [ 0.47, 1.30 ]
Total events: 22 (Formula milk), 29 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.94 (P = 0.35)
3 Motor
O’Connor 2016 13/147 18/149 29.2 % 0.73 [ 0.37, 1.44 ]
Subtotal (95% CI) 147 149 29.2 % 0.73 [ 0.37, 1.44 ]
Total events: 13 (Formula milk), 18 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.90 (P = 0.37)
Total (95% CI) 440 450 100.0 % 0.78 [ 0.55, 1.11 ]
Total events: 47 (Formula milk), 62 (Donor breast milk)
Heterogeneity: Chi2 = 0.05, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Chi2 = 0.05, df = 2 (P = 0.98), I2 =0.0%
0.5 0.7 1 1.5 2
Favours formula milk Favours donor breast milk
63Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.21. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 21 Cerebral palsy.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 21 Cerebral palsy
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
O’Connor 2016 7/148 14/151 100.0 % 0.51 [ 0.21, 1.23 ]
Total (95% CI) 148 151 100.0 % 0.51 [ 0.21, 1.23 ]
Total events: 7 (Formula milk), 14 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 1.22. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 22 Hearing impairment.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 22 Hearing impairment
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
O’Connor 2016 5/148 5/151 100.0 % 1.02 [ 0.30, 3.45 ]
Total (95% CI) 148 151 100.0 % 1.02 [ 0.30, 3.45 ]
Total events: 5 (Formula milk), 5 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.97)
Test for subgroup differences: Not applicable
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Analysis 1.23. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 23 Visual impairment.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 23 Visual impairment
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
O’Connor 2016 0/148 0/151 Not estimable
Total (95% CI) 148 151 Not estimable
Total events: 0 (Formula milk), 0 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 1.24. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 24 All-cause mortality.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 24 All-cause mortality
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Costa 2018 0/35 1/35 2.3 % 0.33 [ 0.01, 7.91 ]
Lucas 1984a 9/76 7/83 10.1 % 1.40 [ 0.55, 3.59 ]
Lucas 1984b 15/173 12/170 18.2 % 1.23 [ 0.59, 2.55 ]
Subtotal (95% CI) 284 288 30.5 % 1.22 [ 0.70, 2.14 ]
Total events: 24 (Formula milk), 20 (Donor breast milk)
Heterogeneity: Chi2 = 0.73, df = 2 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
2 Preterm formula versus fortified DBM
Corpeleijn 2016 23/190 25/183 38.3 % 0.89 [ 0.52, 1.50 ]
Cristofalo 2013 2/24 0/29 0.7 % 6.00 [ 0.30, 119.27 ]
O’Connor 2016 20/182 17/181 25.7 % 1.17 [ 0.63, 2.16 ]
Schanler 2005 3/88 3/78 4.8 % 0.89 [ 0.18, 4.26 ]
Subtotal (95% CI) 484 471 69.5 % 1.04 [ 0.71, 1.52 ]
Total events: 48 (Formula milk), 45 (Donor breast milk)
Heterogeneity: Chi2 = 1.86, df = 3 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 768 759 100.0 % 1.10 [ 0.80, 1.50 ]
Total events: 72 (Formula milk), 65 (Donor breast milk)
Heterogeneity: Chi2 = 2.88, df = 6 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.65), I2 =0.0%
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Analysis 1.25. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 25 Necrotising enterocolitis.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 25 Necrotising enterocolitis
Study or subgroup Favours formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Term formula versus unfortified DBM
Gross 1983 3/26 1/41 2.5 % 4.73 [ 0.52, 43.09 ]
Subtotal (95% CI) 26 41 2.5 % 4.73 [ 0.52, 43.09 ]
Total events: 3 (Favours formula milk), 1 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 1.38 (P = 0.17)
2 Preterm formula versus unfortified DBM
Tyson 1983 1/44 0/37 1.8 % 2.53 [ 0.11, 60.39 ]
Lucas 1984a 4/76 1/83 3.1 % 4.37 [ 0.50, 38.23 ]
Lucas 1984b 5/173 2/170 6.5 % 2.46 [ 0.48, 12.49 ]
Costa 2018 0/35 0/35 Not estimable
Subtotal (95% CI) 328 325 11.4 % 2.99 [ 0.90, 9.87 ]
Total events: 10 (Favours formula milk), 3 (Donor breast milk)
Heterogeneity: Chi2 = 0.18, df = 2 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.80 (P = 0.072)
3 Preterm formula versus fortified DBM
Schanler 2005 10/88 5/78 17.2 % 1.77 [ 0.63, 4.96 ]
Cristofalo 2013 5/24 1/29 2.9 % 6.04 [ 0.76, 48.25 ]
O’Connor 2016 12/182 3/181 9.8 % 3.98 [ 1.14, 13.86 ]
Corpeleijn 2016 17/190 17/183 56.2 % 0.96 [ 0.51, 1.83 ]
Subtotal (95% CI) 484 471 86.1 % 1.64 [ 1.03, 2.61 ]
Total events: 44 (Favours formula milk), 26 (Donor breast milk)
Heterogeneity: Chi2 = 6.12, df = 3 (P = 0.11); I2 =51%
Test for overall effect: Z = 2.09 (P = 0.037)
Total (95% CI) 838 837 100.0 % 1.87 [ 1.23, 2.85 ]
Total events: 57 (Favours formula milk), 30 (Donor breast milk)
Heterogeneity: Chi2 = 8.17, df = 7 (P = 0.32); I2 =14%
Test for overall effect: Z = 2.92 (P = 0.0035)
Test for subgroup differences: Chi2 = 1.57, df = 2 (P = 0.46), I2 =0.0%
0.02 0.1 1 10 50
Favours formula milk Favours breast milk
67Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.26. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 26 Days after birth to establish full enteral feeding.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 26 Days after birth to establish full enteral feeding
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Costa 2018 35 12.3 (7) 35 12.8 (6.5) 84.0 % -0.50 [ -3.66, 2.66 ]
Subtotal (95% CI) 35 35 84.0 % -0.50 [ -3.66, 2.66 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
2 Preterm formula versus fortified DBM
Cristofalo 2013 24 29.3 (14.7) 29 24.6 (11.7) 16.0 % 4.70 [ -2.56, 11.96 ]
Subtotal (95% CI) 24 29 16.0 % 4.70 [ -2.56, 11.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
Total (95% CI) 59 64 100.0 % 0.33 [ -2.57, 3.23 ]
Heterogeneity: Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 0.22 (P = 0.82)
Test for subgroup differences: Chi2 = 1.66, df = 1 (P = 0.20), I2 =40%
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Analysis 1.27. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 27 Feeding intolerance or diarrhoea.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 27 Feeding intolerance or diarrhoea
Study or subgroup Formula milk Donor breast milk
Risk
Difference Weight
Risk
Difference
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Term formula versus unfortified DBM
Gross 1983 6/26 1/41 44.2 % 0.21 [ 0.04, 0.38 ]
Subtotal (95% CI) 26 41 44.2 % 0.21 [ 0.04, 0.38 ]
Total events: 6 (Formula milk), 1 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 2.40 (P = 0.016)
2 Preterm formula versus unfortified DBM
Tyson 1983 2/44 1/37 55.8 % 0.02 [ -0.06, 0.10 ]
Subtotal (95% CI) 44 37 55.8 % 0.02 [ -0.06, 0.10 ]
Total events: 2 (Formula milk), 1 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
Total (95% CI) 70 78 100.0 % 0.10 [ 0.01, 0.19 ]
Total events: 8 (Formula milk), 2 (Donor breast milk)
Heterogeneity: Chi2 = 5.55, df = 1 (P = 0.02); I2 =82%
Test for overall effect: Z = 2.28 (P = 0.022)
Test for subgroup differences: Chi2 = 3.88, df = 1 (P = 0.05), I2 =74%
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Analysis 1.28. Comparison 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or
fortified), Outcome 28 Invasive infection.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 1 Formula (term or preterm) versus donated breast milk (DBM) (unfortified or fortified)
Outcome: 28 Invasive infection
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Preterm formula versus unfortified DBM
Costa 2018 2/35 5/35 3.1 % 0.40 [ 0.08, 1.93 ]
Subtotal (95% CI) 35 35 3.1 % 0.40 [ 0.08, 1.93 ]
Total events: 2 (Formula milk), 5 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
2 Preterm formula versus fortified DBM
Corpeleijn 2016 66/190 67/183 41.7 % 0.95 [ 0.72, 1.25 ]
Cristofalo 2013 19/24 16/29 8.9 % 1.43 [ 0.97, 2.11 ]
O’Connor 2016 35/182 44/181 27.0 % 0.79 [ 0.53, 1.17 ]
Schanler 2005 33/88 30/78 19.4 % 0.98 [ 0.66, 1.44 ]
Subtotal (95% CI) 484 471 96.9 % 0.95 [ 0.80, 1.14 ]
Total events: 153 (Formula milk), 157 (Donor breast milk)
Heterogeneity: Chi2 = 5.15, df = 3 (P = 0.16); I2 =42%
Test for overall effect: Z = 0.51 (P = 0.61)
Total (95% CI) 519 506 100.0 % 0.94 [ 0.79, 1.12 ]
Total events: 155 (Formula milk), 162 (Donor breast milk)
Heterogeneity: Chi2 = 6.54, df = 4 (P = 0.16); I2 =39%
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Chi2 = 1.16, df = 1 (P = 0.28), I2 =14%
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Analysis 2.1. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 1 Weight gain (g/kg/day).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 1 Weight gain (g/kg/day)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Cristofalo 2013 24 17 (7.1) 29 15 (5.8) 4.0 % 2.00 [ -1.54, 5.54 ]
Davies 1977 34 14.7 (4.7) 34 13 (5.4) 8.7 % 1.70 [ -0.71, 4.11 ]
Gross 1983 20 20.4 (2.7) 40 14.9 (3.2) 21.2 % 5.50 [ 3.96, 7.04 ]
Lucas 1984a 30 18 (6) 28 12.8 (2.6) 9.1 % 5.20 [ 2.85, 7.55 ]
Raiha 1976 84 13.8 (2.5) 22 13.6 (2) 51.2 % 0.20 [ -0.79, 1.19 ]
Tyson 1983 42 24.3 (8.2) 34 12.4 (4.8) 5.8 % 11.90 [ 8.94, 14.86 ]
Subtotal (95% CI) 234 187 100.0 % 2.65 [ 1.94, 3.36 ]
Heterogeneity: Chi2 = 79.31, df = 5 (P<0.00001); I2 =94%
Test for overall effect: Z = 7.32 (P < 0.00001)
2 Supplement
Lucas 1984b 56 16.3 (4.5) 59 14.3 (3.1) 48.3 % 2.00 [ 0.58, 3.42 ]
O’Connor 2016 162 25.5 (9.7) 164 23.9 (10) 21.3 % 1.60 [ -0.54, 3.74 ]
Schanler 2005 88 20.1 (6.7) 78 17.1 (5) 30.5 % 3.00 [ 1.21, 4.79 ]
Subtotal (95% CI) 306 301 100.0 % 2.22 [ 1.23, 3.21 ]
Heterogeneity: Chi2 = 1.15, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 4.41 (P = 0.000010)
Test for subgroup differences: Chi2 = 0.49, df = 1 (P = 0.48), I2 =0.0%
-10 -5 0 5 10
Favours breast milk Favours formula milk
71Formula versus donor breast milk for feeding preterm or low birth weight infants (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.2. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 2 Linear growth (crown-heel length
mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 2 Linear growth (crown-heel length mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Cristofalo 2013 24 11.2 (2.8) 29 8.4 (2.1) 17.2 % 2.80 [ 1.44, 4.16 ]
Davies 1977 34 9.3 (2) 34 8.5 (2.4) 28.7 % 0.80 [ -0.25, 1.85 ]
Gross 1983 20 7.2 (1.8) 40 6.4 (1.6) 36.5 % 0.80 [ -0.13, 1.73 ]
Lucas 1984a 12 9.7 (2.2) 14 7.3 (2.4) 10.1 % 2.40 [ 0.63, 4.17 ]
Tyson 1983 42 11 (4) 34 7 (5) 7.4 % 4.00 [ 1.93, 6.07 ]
Subtotal (95% CI) 132 151 100.0 % 1.54 [ 0.98, 2.11 ]
Heterogeneity: Chi2 = 13.98, df = 4 (P = 0.01); I2 =71%
Test for overall effect: Z = 5.37 (P < 0.00001)
2 Supplement
Lucas 1984b 20 9.6 (2.2) 25 8.4 (1.4) 41.2 % 1.20 [ 0.09, 2.31 ]
O’Connor 2016 162 10.7 (4.6) 164 10.1 (4.5) 52.0 % 0.60 [ -0.39, 1.59 ]
Schanler 2005 88 10 (10) 78 12 (8) 6.8 % -2.00 [ -4.74, 0.74 ]
Subtotal (95% CI) 270 267 100.0 % 0.67 [ -0.04, 1.38 ]
Heterogeneity: Chi2 = 4.54, df = 2 (P = 0.10); I2 =56%
Test for overall effect: Z = 1.85 (P = 0.065)
Test for subgroup differences: Chi2 = 3.54, df = 1 (P = 0.06), I2 =72%
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Analysis 2.3. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 3 Head growth (mm/week).
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 3 Head growth (mm/week)
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Cristofalo 2013 24 8.8 (1.8) 29 7.8 (2.6) 18.7 % 1.00 [ -0.19, 2.19 ]
Davies 1977 34 7.4 (1.6) 34 6.8 (2) 35.7 % 0.60 [ -0.26, 1.46 ]
Gross 1983 20 8.8 (2.2) 40 7.7 (1.1) 25.3 % 1.10 [ 0.08, 2.12 ]
Lucas 1984a 25 11 (3.6) 23 8.6 (2.7) 8.2 % 2.40 [ 0.61, 4.19 ]
Tyson 1983 42 12 (2) 34 8 (4) 12.2 % 4.00 [ 2.53, 5.47 ]
Subtotal (95% CI) 145 160 100.0 % 1.36 [ 0.85, 1.88 ]
Heterogeneity: Chi2 = 17.21, df = 4 (P = 0.002); I2 =77%
Test for overall effect: Z = 5.20 (P < 0.00001)
2 Supplement
Lucas 1984b 43 10.1 (2.9) 54 9.4 (2.7) 24.5 % 0.70 [ -0.43, 1.83 ]
O’Connor 2016 162 8.3 (2.9) 164 8.2 (3.2) 70.9 % 0.10 [ -0.56, 0.76 ]
Schanler 2005 88 9 (8) 78 9 (9) 4.6 % 0.0 [ -2.60, 2.60 ]
Subtotal (95% CI) 293 296 100.0 % 0.24 [ -0.32, 0.80 ]
Heterogeneity: Chi2 = 0.84, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Chi2 = 8.37, df = 1 (P = 0.00), I2 =88%
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Analysis 2.4. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 4 Weight (kg) at 9 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 4 Weight (kg) at 9 months post-term
Study or subgroup Favours breast milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 48 7.9 (1.3) 62 7.7 (1.2) 100.0 % 0.20 [ -0.27, 0.67 ]
Subtotal (95% CI) 48 62 100.0 % 0.20 [ -0.27, 0.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
2 Supplement
Lucas 1984b 126 7.9 (1.1) 133 8 (1.1) 100.0 % -0.10 [ -0.37, 0.17 ]
Subtotal (95% CI) 126 133 100.0 % -0.10 [ -0.37, 0.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.46)
Test for subgroup differences: Chi2 = 1.17, df = 1 (P = 0.28), I2 =14%
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Analysis 2.5. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 5 Length (cm) at 9 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 5 Length (cm) at 9 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 48 69.2 (3.7) 62 68.8 (3.3) 100.0 % 0.40 [ -0.93, 1.73 ]
Subtotal (95% CI) 48 62 100.0 % 0.40 [ -0.93, 1.73 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
2 Supplement
Lucas 1984b 126 69.4 (3.2) 133 69.5 (3.2) 100.0 % -0.10 [ -0.88, 0.68 ]
Subtotal (95% CI) 126 133 100.0 % -0.10 [ -0.88, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Chi2 = 0.40, df = 1 (P = 0.53), I2 =0.0%
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Analysis 2.6. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 6 Head circumference (cm) at 9 months
post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 6 Head circumference (cm) at 9 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 48 45.3 (1.8) 62 45.1 (1.6) 100.0 % 0.20 [ -0.45, 0.85 ]
Subtotal (95% CI) 48 62 100.0 % 0.20 [ -0.45, 0.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.61 (P = 0.54)
2 Supplement
Lucas 1984b 126 45.7 (1.6) 133 45.5 (1.5) 100.0 % 0.20 [ -0.18, 0.58 ]
Subtotal (95% CI) 126 133 100.0 % 0.20 [ -0.18, 0.58 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 1.00), I2 =0.0%
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Analysis 2.7. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 7 Weight (kg) at 18 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 7 Weight (kg) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 64 10 (1.3) 72 9.9 (1.5) 100.0 % 0.10 [ -0.37, 0.57 ]
Subtotal (95% CI) 64 72 100.0 % 0.10 [ -0.37, 0.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
2 Supplement
Lucas 1984b 153 10.1 (1.3) 149 10 (1.3) 100.0 % 0.10 [ -0.19, 0.39 ]
Subtotal (95% CI) 153 149 100.0 % 0.10 [ -0.19, 0.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 1.00), I2 =0.0%
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Analysis 2.8. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 8 Length (cm) at 18 months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 8 Length (cm) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 64 79.3 (3.7) 72 78.7 (3.9) 100.0 % 0.60 [ -0.68, 1.88 ]
Subtotal (95% CI) 64 72 100.0 % 0.60 [ -0.68, 1.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.92 (P = 0.36)
2 Supplement
Lucas 1984b 153 79.5 (3.8) 149 79 (3.2) 100.0 % 0.50 [ -0.29, 1.29 ]
Subtotal (95% CI) 153 149 100.0 % 0.50 [ -0.29, 1.29 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.24 (P = 0.22)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.90), I2 =0.0%
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Analysis 2.9. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 9 Head circumference (cm) at 18
months post-term.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 9 Head circumference (cm) at 18 months post-term
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 64 47.7 (1.5) 72 47.6 (1.7) 100.0 % 0.10 [ -0.44, 0.64 ]
Subtotal (95% CI) 64 72 100.0 % 0.10 [ -0.44, 0.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
2 Supplement
Lucas 1984b 153 48.2 (1.6) 149 48.1 (1.5) 100.0 % 0.10 [ -0.25, 0.45 ]
Subtotal (95% CI) 153 149 100.0 % 0.10 [ -0.25, 0.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Chi2 = 0.0, df = 1 (P = 1.00), I2 =0.0%
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Analysis 2.10. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 10 Weight (kg) at 7.5 to 8 years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 10 Weight (kg) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 62 22.3 (5.1) 68 21.8 (5) 100.0 % 0.50 [ -1.24, 2.24 ]
Subtotal (95% CI) 62 68 100.0 % 0.50 [ -1.24, 2.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.57)
2 Supplement
Lucas 1984b 151 22.3 (3.6) 139 23.2 (4.8) 100.0 % -0.90 [ -1.88, 0.08 ]
Subtotal (95% CI) 151 139 100.0 % -0.90 [ -1.88, 0.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.79 (P = 0.073)
Test for subgroup differences: Chi2 = 1.89, df = 1 (P = 0.17), I2 =47%
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Analysis 2.11. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 11 Length (cm) at 7.5 to 8 years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 11 Length (cm) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 62 120.4 (6.6) 68 119.4 (6.5) 27.3 % 1.00 [ -1.26, 3.26 ]
Subtotal (95% CI) 62 68 27.3 % 1.00 [ -1.26, 3.26 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
2 Supplement
Lucas 1984b 151 121.3 (6.4) 139 121.6 (5.6) 72.7 % -0.30 [ -1.68, 1.08 ]
Subtotal (95% CI) 151 139 72.7 % -0.30 [ -1.68, 1.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
Total (95% CI) 213 207 100.0 % 0.05 [ -1.12, 1.23 ]
Heterogeneity: Chi2 = 0.93, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.09 (P = 0.93)
Test for subgroup differences: Chi2 = 0.93, df = 1 (P = 0.34), I2 =0.0%
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Analysis 2.12. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 12 Head circumference (cm) at 7.5 to 8
years of age.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 12 Head circumference (cm) at 7.5 to 8 years of age
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 62 51.9 (1.5) 68 51.8 (2.3) 28.2 % 0.10 [ -0.56, 0.76 ]
Subtotal (95% CI) 62 68 28.2 % 0.10 [ -0.56, 0.76 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.77)
2 Supplement
Lucas 1984b 151 52.2 (1.9) 139 52.5 (1.7) 71.8 % -0.30 [ -0.71, 0.11 ]
Subtotal (95% CI) 151 139 71.8 % -0.30 [ -0.71, 0.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 213 207 100.0 % -0.19 [ -0.54, 0.16 ]
Heterogeneity: Chi2 = 1.01, df = 1 (P = 0.32); I2 =1%
Test for overall effect: Z = 1.05 (P = 0.30)
Test for subgroup differences: Chi2 = 1.01, df = 1 (P = 0.32), I2 =1%
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Analysis 2.13. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 13 Bayley Mental Development Index at
18 months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 13 Bayley Mental Development Index at 18 months
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 52 95.3 (19.5) 62 94.8 (16.5) 100.0 % 0.50 [ -6.21, 7.21 ]
Subtotal (95% CI) 52 62 100.0 % 0.50 [ -6.21, 7.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
2 Supplement
Lucas 1984b 139 103.8 (20) 134 102.2 (19.7) 100.0 % 1.60 [ -3.11, 6.31 ]
Subtotal (95% CI) 139 134 100.0 % 1.60 [ -3.11, 6.31 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.51)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.79), I2 =0.0%
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Analysis 2.14. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 14 Bayley Psychomotor Development
Index at 18 months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 14 Bayley Psychomotor Development Index at 18 months
Study or subgroup Formula milk Donor breast milk
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Sole diet
Lucas 1984a 52 94.2 (15.9) 62 93 (14.2) 100.0 % 1.20 [ -4.38, 6.78 ]
Subtotal (95% CI) 52 62 100.0 % 1.20 [ -4.38, 6.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
2 Supplement
Lucas 1984b 139 94.5 (16.5) 134 95.5 (15) 100.0 % -1.00 [ -4.74, 2.74 ]
Subtotal (95% CI) 139 134 100.0 % -1.00 [ -4.74, 2.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Chi2 = 0.41, df = 1 (P = 0.52), I2 =0.0%
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Analysis 2.15. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 15 Neurodevelopmental disability at 18
months.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 15 Neurodevelopmental disability at 18 months
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sole diet
Lucas 1984a 7/56 4/66 100.0 % 2.06 [ 0.64, 6.68 ]
Subtotal (95% CI) 56 66 100.0 % 2.06 [ 0.64, 6.68 ]
Total events: 7 (Formula milk), 4 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.23)
2 Supplement
Lucas 1984b 10/138 11/140 100.0 % 0.92 [ 0.40, 2.10 ]
Subtotal (95% CI) 138 140 100.0 % 0.92 [ 0.40, 2.10 ]
Total events: 10 (Formula milk), 11 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Chi2 = 1.21, df = 1 (P = 0.27), I2 =17%
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Analysis 2.16. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 16 All-cause mortality.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 16 All-cause mortality
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sole diet
Cristofalo 2013 2/24 0/29 6.4 % 6.00 [ 0.30, 119.27 ]
Lucas 1984a 9/76 7/83 93.6 % 1.40 [ 0.55, 3.59 ]
Subtotal (95% CI) 100 112 100.0 % 1.70 [ 0.71, 4.07 ]
Total events: 11 (Formula milk), 7 (Donor breast milk)
Heterogeneity: Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 1.18 (P = 0.24)
2 Supplement
Corpeleijn 2016 23/190 25/183 42.9 % 0.89 [ 0.52, 1.50 ]
Costa 2018 0/35 1/35 2.5 % 0.33 [ 0.01, 7.91 ]
Lucas 1984b 15/173 12/170 20.4 % 1.23 [ 0.59, 2.55 ]
O’Connor 2016 20/182 17/181 28.7 % 1.17 [ 0.63, 2.16 ]
Schanler 2005 3/88 3/78 5.4 % 0.89 [ 0.18, 4.26 ]
Subtotal (95% CI) 668 647 100.0 % 1.02 [ 0.73, 1.44 ]
Total events: 61 (Formula milk), 58 (Donor breast milk)
Heterogeneity: Chi2 = 1.22, df = 4 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.13 (P = 0.89)
Test for subgroup differences: Chi2 = 1.11, df = 1 (P = 0.29), I2 =10%
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Analysis 2.17. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 17 Necrotising enterocolitis.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 17 Necrotising enterocolitis
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sole diet
Cristofalo 2013 5/24 1/29 28.5 % 6.04 [ 0.76, 48.25 ]
Gross 1983 3/26 1/41 24.4 % 4.73 [ 0.52, 43.09 ]
Lucas 1984a 4/76 1/83 30.1 % 4.37 [ 0.50, 38.23 ]
Tyson 1983 1/44 0/37 17.0 % 2.53 [ 0.11, 60.39 ]
Subtotal (95% CI) 170 190 100.0 % 4.62 [ 1.47, 14.56 ]
Total events: 13 (Formula milk), 3 (Donor breast milk)
Heterogeneity: Chi2 = 0.20, df = 3 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 2.61 (P = 0.0090)
2 Supplement
Corpeleijn 2016 17/190 17/183 62.6 % 0.96 [ 0.51, 1.83 ]
Costa 2018 0/35 0/35 Not estimable
Lucas 1984b 5/173 2/170 7.3 % 2.46 [ 0.48, 12.49 ]
O’Connor 2016 12/182 3/181 10.9 % 3.98 [ 1.14, 13.86 ]
Schanler 2005 10/88 5/78 19.2 % 1.77 [ 0.63, 4.96 ]
Subtotal (95% CI) 668 647 100.0 % 1.56 [ 0.98, 2.47 ]
Total events: 44 (Formula milk), 27 (Donor breast milk)
Heterogeneity: Chi2 = 4.69, df = 3 (P = 0.20); I2 =36%
Test for overall effect: Z = 1.87 (P = 0.061)
Test for subgroup differences: Chi2 = 2.97, df = 1 (P = 0.08), I2 =66%
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Analysis 2.18. Comparison 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole
diet or (ii) a supplement to maternal expressed breast milk, Outcome 18 Incidence of invasive infection.
Review: Formula versus donor breast milk for feeding preterm or low birth weight infants
Comparison: 2 Subgroup analysis: formula versus donated breast milk (DBM) given as (i) sole diet or (ii) a supplement to maternal expressed breast milk
Outcome: 18 Incidence of invasive infection
Study or subgroup Formula milk Donor breast milk Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Sole diet
Cristofalo 2013 19/24 16/29 100.0 % 1.43 [ 0.97, 2.11 ]
Subtotal (95% CI) 24 29 100.0 % 1.43 [ 0.97, 2.11 ]
Total events: 19 (Formula milk), 16 (Donor breast milk)
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
2 Supplement
Corpeleijn 2016 66/190 67/183 45.8 % 0.95 [ 0.72, 1.25 ]
Costa 2018 2/35 5/35 3.4 % 0.40 [ 0.08, 1.93 ]
O’Connor 2016 35/182 44/181 29.6 % 0.79 [ 0.53, 1.17 ]
Schanler 2005 33/88 30/78 21.3 % 0.98 [ 0.66, 1.44 ]
Subtotal (95% CI) 495 477 100.0 % 0.89 [ 0.73, 1.08 ]
Total events: 136 (Formula milk), 146 (Donor breast milk)
Heterogeneity: Chi2 = 1.76, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 1.19 (P = 0.23)
Test for subgroup differences: Chi2 = 4.70, df = 1 (P = 0.03), I2 =79%
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A P P E N D I C E S
Appendix 1. Electronic search strategy
CINAHL via EBSCO
Search ID# Search Terms
S1 (MH “Infant, Newborn+”)
S2 TX ( (neonat* or neo nat*) ) OR TX ( (newborn* or new born* or newly born*) ) OR TX ( (preterm or preterms
or pre term or pre terms) ) OR TX ( (preemie$ or premie or premies) ) OR TX ( (prematur* N3 (birth* or born or
deliver*)) ) OR TX ( (low N3 (birthweight* or birth weight*)) ) OR TX ( (lbw or vlbw or elbw) ) OR TX infan* OR
TX ( (baby or babies) )
S3 S1 OR S2
S4 (MH “Infant Formula”)
S5 TX infant* N2 formula* OR TX pediatric N2 formula* OR TX paediatric N2 formula* OR TX ( (baby or babies)
N2 formula* ) OR TX formula* N2 milk
S6 S4 OR S5
S7 (MH “Milk, Human”) OR (MH “Milk Banks”)
S8 TX Milk N2 bank* OR TX ( milk N2 (donor* or donat*) ) OR TX milk N2 shar* OR TX breastmilk N2 bank* OR
TX ( breastmilk N2 (donor* or donat*) ) OR TX breastmilk N2 shar* OR TX ( milk N10 (DBM or DHM) )
S9 S7 OR S8
S10 S3 AND S6 AND S9
S11 (MH “Randomized Controlled Trials”) OR (MH “Clinical Trials”)
S12 (MH “Comparative Studies”)
S13 (MH “Evaluation Research”)
S14 S11 OR S12 OR S13
S15 S10 AND S14
Cochrane Central Register of Controlled Trials (CENTRAL) via John Wiley’s Cochrane Library
#1 MeSH descriptor: [Infant, Newborn] explode all trees
#2 MeSH descriptor: [Premature Birth] explode all trees
#3 neonat* or “neo nat*”:ti,ab,kw or newborn* or “new born*” or “newly born*”:ti,ab,kw or preterm or preterms or “pre term” or “pre
terms”:ti,ab,kw or preemie* or premie or premies:ti,ab,kw or prematur* near/3 (birth* or born or deliver*):ti,ab,kw (Word variations
have been searched)
#4 low near/3 (birthweight* or “birth weight*”):ti,ab,kw or lbw or vlbw or elbw:ti,ab,kw or infan*:ti,ab,kw or baby or babies:ti,ab,kw
(Word variations have been searched)
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#5 #1 or #2 or #3 or #4
#6 MeSH descriptor: [Infant Formula] explode all trees
#7 infant* near/2 formula*:ti,ab,kw or pediatric near/2 formula*:ti,ab,kw and paediatric near/2 formula*:ti,ab,kw or (baby or babies)
near/2 formula*:ti,ab,kw or formula* near/2 milk:ti,ab,kw (Word variations have been searched)
#8 #6 or #7
#9 MeSH descriptor: [Milk, Human] explode all trees
#10 MeSH descriptor: [Milk Banks] explode all trees
#11 Milk near/2 (bank* or donor* or donat* or shar*):ti,ab,kw or Breastmilk near/2 (bank* or donor* or donat* or shar*):ti,ab,kw or
milk near/10 (DBM or DHM):ti,ab,kw (Word variations have been searched)
#12 #9 or #10 or #11
#13 #5 and #8 and #12
Embase via OVID
1 Newborn/
2 Prematurity/
3 (neonat$ or neo nat$).ti,ab.
4 (newborn$ or new born$ or newly born$).ti,ab.
5 (preterm or preterms or pre term or pre terms).ti,ab.
6 (preemie$ or premie or premies).ti,ab.
7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab.
8 (low adj3 (birthweight$ or birth weight$)).ti,ab.
9 (lbw or vlbw or elbw).ti,ab.
10 infan$.ti,ab.
11 (baby or babies).ti,ab.
12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 (
13 Artifical milk/
14 (infant$ adj2 formula$).ti,ab.
15 (pediatric adj2 formula$).ti,ab.
16 (paediatric adj2 formula$).ti,ab.
17 ((baby or babies) adj2 formula$).ti,ab.
18 (formula$ adj2 milk).ti,ab.
19 13 or 14 or 15 or 16 or 17 or 18
20 Breast milk/
21 Milk Bank/
22 (Milk adj2 bank$).ti,ab.
23 (milk adj2 (donor$ or donat$)).ti,ab.
24 (milk adj2 shar$).ti,ab.
25 (breastmilk adj2 bank$).ti,ab.
26 (breastmilk adj2 (donor$ or donat$)).ti,ab.
27 (breastmilk adj2 shar$).ti,ab.
28 (milk and (DBM or DHM)).ti,ab.
29 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
30 12 and 19 and 29
31 (random* or factorial* or placebo* or assign* or allocat* or crossover*).tw.
32 (cross adj over*).tw.
33 (trial* and (control* or comparative)).tw.
34 ((blind* or mask*) and (single or double or triple or treble)).tw.
35 (treatment adj arm*).tw.
36 (control* adj group*).tw.
37 (phase adj (III or three)).tw.
38 (versus or vs).tw.
39 rct.tw.
40 Crossover Procedure/
41 Double Blind Procedure/
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42 Single Blind Procedure/
43 Randomization/
44 Placebo/
45 exp Clinical Trial/
46 Parallel Design/
47 Latin Square Design/
48 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47
49 exp animal/ or exp nonhuman/ or exp animal experiment/ or exp animal model/
50 exp human/
51 49 not 50
52 48 not 51
53 30 and 52
Maternity & Infant Care via OVID
1 (neonat$ or neo nat$).ti,ab.
2 (newborn$ or new born$ or newly born$).ti,ab.
3 (preterm or preterms or pre term or pre terms).ti,ab.
4 (preemie$ or premie or premies).ti,ab.
5 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab.
6 (low adj3 (birthweight$ or birth weight$)).ti,ab.
7 (lbw or vlbw or elbw).ti,ab.
8 infan$.ti,ab.
9 (baby or babies).ti,ab.
10 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11 (infant$ adj2 formula$).ti,ab.
12 (pediatric adj2 formula$).ti,ab.
13 (paediatric adj2 formula$).ti,ab.
14 ((baby or babies) adj2 formula$).ti,ab.
15 (formula$ adj2 milk).ti,ab.
16 11 or 12 or 13 or 14 or 15
17 Human milk.ti,ab.
18 (Milk adj2 bank$).ti,ab.
19 (milk adj2 (donor$ or donat$)).ti,ab.
20 (milk adj2 shar$).ti,ab. (39)
21 (breastmilk adj2 bank$).ti,ab.
22 (breastmilk adj2 (donor$ or donat$)).ti,ab.
23 (breastmilk adj2 shar$).ti,ab.
24 (milk and (DBM or DHM)).ti,ab.
25 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
26 10 and 16 and 25
27 limit 26 to randomised controlled trial
MEDLINE via Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R)
Daily and Ovid MEDLINE(R) <1946 to Present>
1 exp Infant, Newborn/
2 Premature Birth/
3 (neonat$ or neo nat$).ti,ab.
4 (newborn$ or new born$ or newly born$).ti,ab.
5 (preterm or preterms or pre term or pre terms).ti,ab.
6 (preemie$ or premie or premies).ti,ab.
7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab.
8 (low adj3 (birthweight$ or birth weight$)).ti,ab.
9 (lbw or vlbw or elbw).ti,ab.
10 infan$.ti,ab.
11 (baby or babies).ti,ab.
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12 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
13 Infant Formula/
14 (infant$ adj2 formula$).ti,ab.
15 (pediatric adj2 formula$).ti,ab.
16 (paediatric adj2 formula$).ti,ab.
17 ((baby or babies) adj2 formula$).ti,ab.
18 (formula$ adj2 milk).ti,ab.
19 13 or 14 or 15 or 16 or 17 or 18
20 Milk, Human/
21 Milk Banks/
22 (Milk adj2 bank$).ti,ab.
23 (milk adj2 (donor$ or donat$)).ti,ab.
24 (milk adj2 shar$).ti,ab.
25 (breastmilk adj2 bank$).ti,ab.
26 (breastmilk adj2 (donor$ or donat$)).ti,ab.
27 (breastmilk adj2 shar$).ti,ab.
28 (milk and (DBM or DHM)).ti,ab.
29 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28
30 12 and 19 and 29
31 randomized controlled trial.pt.
32 controlled clinical trial.pt.
33 randomized.ab.
34 placebo.ab.
35 drug therapy.fs.
36 randomly.ab.
37 trial.ab.
38 groups.ab.
39 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38
40 exp animals/ not humans.sh.
41 39 not 40
42 30 and 41
Appendix 2. ’Risk of bias’ tool
1. Sequence generation (checking for possible selection bias). Was the allocation sequence adequately generated?
For each included study, we categorised the method used to generate the allocation sequence as:
• low risk (any truly random process, e.g. random number table; computer random number generator);
• high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number); or
• unclear risk.
2. Allocation concealment (checking for possible selection bias). Was allocation adequately concealed?
For each included study, we categorised the method used to conceal the allocation sequence as:
• low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);
• high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth); or
• unclear risk.
3. Blinding of participants and personnel (checking for possible performance bias). Was knowledge of the allocated intervention
adequately prevented during the study?
For each included study, we categorised the methods used to blind study participants and personnel from knowledge of which
intervention a participant received. Blinding was assessed separately for different outcomes or class of outcomes. We categorised the
methods as:
• low risk, high risk or unclear risk for participants; and
• low risk, high risk or unclear risk for personnel.
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4. Blinding of outcome assessment (checking for possible detection bias). Was knowledge of the allocated intervention adequately
prevented at the time of outcome assessment?
For each included study, we categorised the methods used to blind outcome assessment. Blinding was assessed separately for different
outcomes or class of outcomes. We categorised the methods as:
• low risk for outcome assessors;
• high risk for outcome assessors; or
• unclear risk for outcome assessors.
5. Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations). Were
incomplete outcome data adequately addressed?
For each included study and for each outcome, we described the completeness of data including attrition and exclusions from the
analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with
the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across
groups or were related to outcomes. Where sufficient information was reported or supplied by the trial authors, we reincluded missing
data in the analyses. We categorised the methods as:
• low risk (< 20% missing data);
• high risk (≥ 20% missing data); or
• unclear risk.
6. Selective reporting bias. Are reports of the study free of suggestion of selective outcome reporting?
For each included study, we described how we investigated the possibility of selective outcome reporting bias and what we found. For
studies in which study protocols were published in advance, we compared prespecified outcomes versus outcomes eventually reported
in the published results. If the study protocol was not published in advance, we contacted study authors to gain access to the study
protocol. We assessed the methods as:
• low risk (where it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have
been reported);
• high risk (where not all the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not
prespecified outcomes of interest and are reported incompletely and so cannot be used; study fails to include results of a key outcome
that would have been expected to have been reported); or
• unclear risk.
7. Other sources of bias. Was the study apparently free of other problems that could put it at a high risk of bias?
For each included study, we described any important concerns we had about other possible sources of bias (for example, whether there
was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data-dependent
process). We assessed whether each study was free of other problems that could put it at risk of bias as:
• low risk;
• high risk;
• unclear risk.
If needed, we explored the impact of the level of bias through undertaking sensitivity analyses.
Appendix 3. GRADE
GRADE considers that evidence from randomised controlled trials is high certainty, but that assessment may be downgraded based on
consideration of any of five areas.
• Design (risk of bias).
• Consistency across studies.
• Directness of the evidence.
• Precision of estimates.
• Presence of publication bias.
This results in an assessment of the certainty of a body of evidence in one of four grades.:
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
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Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect,
but there is a possibility that it is substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the
effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the
estimate of effect.
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